2026 | ChiroMed

April 24, 2026

BHRT: What to Expect With Hormones & Pellet Therapy

Understand the impact of BHRT and pellet therapy on your hormonal health and how they can improve your quality of life.

Abstract

Hello, I’m Dr. Alexander Jimenez. Welcome to this educational exploration of hormone health and integrative care. In my practice, which combines chiropractic care with advanced functional and integrative medicine, I have seen firsthand the profound impact hormonal balance has on overall health. This post is designed to guide you through the sophisticated, evidence-based approaches we use to manage hormonal imbalances, particularly those associated with perimenopause, menopause, and andropause. We will begin by outlining the streamlined patient journey in our clinic, from initial contact to follow-up care, highlighting the use of modern tools, such as QR code campaigns, to enhance patient education. Following this, we will dive into detailed case studies of both a female and a male patient. Through these real-world examples, I will break down the interpretation of comprehensive lab work, discussing key biomarkers like ferritin, thyroid-stimulating hormone (TSH), free testosterone, and Estradiol. We’ll explore the physiological significance of these markers and how they inform our treatment decisions, including the use of Bioidentical Hormone Replacement Pellet Therapy (BHRT). I will also detail the precision of the pellet insertion procedure itself and discuss the critical role of integrative chiropractic care in addressing the musculoskeletal and neurological symptoms that often accompany hormonal shifts. Our goal is to present a holistic, patient-centered model that combines cutting-edge research with personalized clinical care to optimize health and well-being.

Revolutionizing the Patient Experience: A Streamlined Clinical Workflow

Over my years in practice, I’ve observed a significant paradigm shift in how we approach patient care, especially in the realm of hormonal health. The journey to wellness must be clear, efficient, and supportive. I want to walk you through the workflow we have refined in our clinics, which serves as a roadmap for both our patients and our providers.
Our process begins the moment a potential patient expresses interest.

Initial Contact and Lab Initiation: When someone calls our office, we schedule them for an initial provider consultation. Critically, we don’t wait for that first appointment to start gathering information. We immediately initiate a comprehensive lab panel tailored to their likely needs. This proactive step ensures that when I first sit down with a patient, we have objective data to guide our conversation.
Empowering Through Education: The QR Code Campaign: About 13 years ago, working with a business coach, I had a realization: we were repeating the same foundational information to every new patient. While necessary, it consumed valuable consultation time that could be better spent on a personalized strategy. This led to the creation of our QR code educational campaigns. Before their first visit, patients receive access to a series of short, digestible videos. These videos answer common questions about hormone therapy, explain the process, and demystify the science. By the time they come in to review their labs, they are already educated and empowered, allowing us to have a much deeper and more productive conversation.
The Comprehensive Consultation: During the consultation, we review several key items together:
- Symptom Checklists: We use validated tools such as the Menopausal Rating Scale (MRS) and our Bioidentical Hormone Replacement Therapy (BHRT) symptom checklist.
- Lab Results: We conduct a thorough, line-by-line review of their comprehensive lab work.
- Treatment Options: We discuss all available treatment modalities. In our office, this includes pellets, injections, and creams. We present the pros and cons of each, allowing the patient to make an informed choice that aligns with their lifestyle and preferences.

Once a treatment plan is decided upon, we schedule the procedure. Before they leave, we also schedule their follow-up lab work. In the early days, we used to tell patients to come back when they “felt” their symptoms returning. This was a mistake. The decline is often so gradual that patients don’t recognize it until they feel significantly unwell again, leading to poor retention and inconsistent results. Now, we pre-schedule follow-up labs—typically at 14 weeks for women and 18 weeks for men—to stay ahead of the curve and maintain optimal levels. This proactive approach is key to long-term success.

The Critical Role of Informed Consent and Patient Education

In medicine, documentation is paramount. The informed consent process is not merely a legal formality to protect the practitioner; it is a cornerstone of ethical care that justifies and explains the entire treatment plan. Our consent forms are comprehensive educational documents. They explicitly detail why we believe in BHRT and reference the scientific literature supporting its use. We are transparent about the off-label nature of custom-compounded hormone pellets. While the hormones themselves (testosterone, estradiol) are FDA-approved, their use in the form of compounded pellets for indications such as improving well-being and mitigating age-related symptoms is considered off-label.
The consent form explains the rationale for using pellets, the specific labs and diagnostic criteria used, potential side effects, and the critical importance of adherence. By having the patient read and sign this detailed document, we ensure they can never say, “I was never told.” This level of transparency builds trust and protects both the patient and the provider.

Case Study 1: Decoding Menopausal Symptoms in a 59-Year-Old Female

Let’s delve into a representative case to see how this process plays out. This patient is a 59-year-old female presenting with common complaints associated with post-menopause.
Her Menopausal Rating Scale (MRS) reveals a significant symptom burden. The scale, which is numerically scored, shows she is experiencing severe symptoms, particularly in the realms of mood (depressive symptoms) and sexual health (diminished desire). Her score is far from the ideal post-treatment goal. This subjective data is our starting point; it’s the patient’s lived experience.

Comprehensive Lab Analysis: Uncovering the Root Causes

Next, we turn to her objective lab data. A full understanding requires looking beyond just the sex hormones.

Ferritin: Her ferritin level is a point of concern. Ferritin is the body’s primary iron storage protein. A low ferritin level, even if hemoglobin and hematocrit are normal, can mimic and exacerbate symptoms of hormonal imbalance, such as fatigue, hair loss, and brain fog. Before initiating hormone therapy, it is crucial to optimize iron stores. In her case, I would recommend a daily dose of a high-quality iron supplement.
Vitamin D: Her Vitamin D level is also suboptimal. Vitamin D, a pro-hormone, is essential for immune function, bone health, and mood regulation. Research, such as that highlighted by Holick (2007), underscores its systemic importance. For a patient like this, I would typically start with a dose of 5,000 IU daily to bring her levels into the optimal range, which can also help mitigate inflammatory processes.
Thyroid Panel:
- Her Thyroid-Stimulating Hormone (TSH) is 3.8 mIU/L. While this may fall within a “normal” lab reference range, the functional and anti-aging medicine communities, supported by a growing body of literature, advocate for a much narrower optimal range, typically below 2.5 mIU/L (Jabbar et al., 2021). A TSH of 3.8 suggests her thyroid is working too hard, a sign of subclinical hypothyroidism.
- Her Free T3 is suboptimal. T3 is the active thyroid hormone that drives metabolism in every cell of the body.
- Her Free T4 is 0.8 ng/dL. This is also on the low end of the optimal range.

My immediate thought is that her thyroid is sluggish. The brain’s pituitary gland is releasing more TSH to “yell” at the thyroid, which is under-responding. This is a classic feedback loop issue that contributes significantly to her fatigue, weight gain, and depressive mood.

Sex Hormones:
- Her Free Testosterone is functionally zero. This is a critical finding. While often considered a “male” hormone, testosterone is vital for women’s energy, mood, cognitive function, muscle mass, and libido. A level this low is a primary driver of her symptoms.
- Her Estradiol is 18 pg/mL. For a post-menopausal woman, this isn’t dangerously low, but it’s far from optimal for symptom relief and protection against bone loss and cognitive decline. Research by Santoro, Roeca, and Peters (2021) clearly outlines the systemic effects of estrogen decline. The brain is literally starving for these hormones.

The Treatment Plan: BHRT and Integrative Chiropractic Care

Based on these findings, this patient is a clear candidate for Bioidentical Hormone Replacement Pellet Therapy (BHRT). My goal is to restore estradiol and testosterone to levels reminiscent of her pre-menopausal state, where she felt her best. This is not about achieving supra-physiological levels but about restoring physiological balance.
This is also where integrative chiropractic care becomes essential. Hormonal decline, particularly the loss of estrogen and testosterone, directly impacts musculoskeletal integrity.

Musculoskeletal Support: Patients often report new aches, joint stiffness, and a sense of physical fragility. The “meno-belly” she describes—a sudden accumulation of visceral fat around the midsection despite no changes in diet or exercise—is a classic sign of hormonal shift, driven by cortisol and insulin dysregulation secondary to low estrogen. Chiropractic adjustments help restore proper joint mobility and alleviate pain. We also incorporate specific soft tissue therapies to address muscle tension and fascial restrictions that develop.
Neurological Regulation: The nervous system and endocrine system are intricately linked. Spinal misalignments can interfere with the signaling of the hypothalamic-pituitary-adrenal (HPA) axis, which governs our stress response and hormone production. By performing targeted chiropractic adjustments, we can help normalize neurological feedback loops, reduce sympathetic (fight-or-flight) overdrive, and support the body’s overall ability to adapt and heal. This is particularly important for managing the anxiety and sleep disturbances that accompany menopause.

For this patient, the plan is multifaceted: initiate BHRT to address foundational hormonal deficiencies; supplement to correct her vitamin D and ferritin levels; provide nutritional guidance to support her thyroid and manage inflammation; and implement regular chiropractic care to address the structural and neurological consequences of her hormonal state.

Assessing Hormone Therapy- Video

Case Study 2: Addressing Andropause in a Male Patient

Now, let’s consider a male patient presenting with symptoms of andropause, the male equivalent of menopause. He reports a classic constellation of symptoms on the Aging Male Symptoms (AMS) scale: low libido, decreased stamina, loss of morning erections, increased visceral fat (a “pot belly”), and general GI issues.

Interpreting the Male Lab Panel

His lab work paints a stark picture of metabolic and hormonal decline.

Kidney Function: His elevated creatinine is an immediate flag for impaired kidney function. My first step is to educate him on this finding and ensure he follows up with his primary care provider or a nephrologist. We must work collaboratively and ensure all aspects of a patient’s health are monitored.
Bone Density: He has signs of osteopenia. I would educate him about the importance of a DEXA scan to get a precise measure of his bone mineral density. Testosterone is crucial for maintaining bone health in men, and its decline is a major risk factor for osteoporosis (Mohamad et al., 2016).
Metabolic Markers:
- His Hemoglobin A1c indicates prediabetes.
- His C-Reactive Protein (CRP), a marker of systemic inflammation, is elevated.
- He has hypertension and high cholesterol.
Sex Hormones:
- His Total Testosterone is 122 ng/dL. This is profoundly low. Optimal levels for a man should be in the 700-900 ng/dL range. A level of 122 is not just a quality-of-life issue; it is a medical issue that drives his metabolic disease. Low testosterone is directly linked to an increased risk of diabetes, heart disease, and cognitive decline.
- His Sex Hormone-Binding Globulin (SHBG) is very low. SHBG is a protein that binds to testosterone, making it unavailable to the tissues. While a low SHBG might seem good because it means more “free” testosterone is theoretically available, in the context of his overall metabolic dysfunction, it’s another sign of insulin resistance and inflammation.

The Comprehensive Treatment Protocol for Andropause

This patient is a prime candidate for Testosterone Pellet Therapy. Restoring his testosterone to an optimal physiological range is the single most effective intervention to address the root cause of his myriad symptoms. As with our female patient, integrative chiropractic care is a cornerstone of his treatment. Low testosterone is associated with sarcopenia (age-related muscle loss) and joint pain.

Biomechanical Optimization: We use chiropractic adjustments to ensure his spine and extremities are functioning optimally, providing a stable foundation for the renewed exercise and physical activity that testosterone therapy will enable.
Pain Management: We address the chronic aches and pains that have likely made him more sedentary, creating a vicious cycle of inactivity and further decline.
Lifestyle Coaching: As part of our integrative model, we provide targeted advice on resistance training and nutrition to maximize the benefits of his hormone therapy, helping him rebuild muscle, lose fat, and reclaim his vitality.

By combining cutting-edge BHRT with foundational chiropractic care and lifestyle medicine, we can dramatically alter the trajectory of his health, moving him from a state of metabolic disease and low vitality to one of optimal function and well-being.

The Art and Science of Pellet Insertion Technique

The physical procedure of pellet insertion has evolved significantly. The technique used is just as important as the dosage itself, as it directly impacts hormone absorption, efficacy, and patient comfort. We have moved far beyond outdated methods that caused unnecessary trauma and inconsistent results. Today, we use a much more elegant and effective no-scalpel, micro-tunneling technique that prioritizes precision and minimizes tissue trauma.

Preparation and Anesthesia: After preparing a sterile field, we use a two-step numbing process to anesthetize the deep fatty layer of the upper gluteal region, well above the muscle.
The Incision and Trocar: A tiny incision is made parallel to Langer’s lines (natural skin tension lines) to promote better healing and minimize scarring. We then use a specialized blunt-tipped instrument called a trocar to gently separate the fatty tissue and create small, separate tunnels or “tracks”. This avoids cutting through tissue, which reduces trauma and bleeding.
Layered Pellet Placement: We carefully lay the pellets down in these individual tracks, fanning them out like the spokes of a wheel. This technique is revolutionary because it maximizes the surface area for neovascularization—the formation of new blood vessels. These tiny capillaries grow around each pellet, creating a rich vascular network that ensures slow, steady, and consistent hormone absorption over several months.
Bandaging for Optimal Healing: We close the small incision with Steri-Strips to approximate the wound edges, then apply a multi-layered dressing. This includes a sterile gauze pad, a protective “T” formation with medical tape to prevent accidental removal, and a final waterproof bandage. This meticulous process is designed to promote rapid healing and prevent complications.

Proper post-procedural care, including keeping the area dry and avoiding strenuous activity for several days, is essential to prevent infection and ensure the best possible outcome.

Follow-Up and Long-Term Management: The Art of Titration

Hormone therapy is a dynamic process, not a one-size-fits-all-for-life solution. The goal of the first round of pellets is to fill the patient’s “empty tank.” Subsequent rounds are about maintenance and fine-tuning. After about four to six weeks, we re-check labs. I often see cases where a patient feels “amazing,” but their lab values haven’t reached our definition of the optimal range. This tells me we can further optimize their dose for even better, longer-lasting results.
Conversely, a patient will not require the same large initial dose for their second round. Continuing to give the same high dose would eventually lead to symptoms of excess. This is where clinical acumen comes into play. We must listen to the patient’s subjective experience and titrate their dose based on a combination of their symptoms and lab values. This is a partnership. By managing expectations and adjusting the course as needed, we can guide our patients toward vibrant health and a dramatically improved quality of life.

References

Guo, S., & DiPietro, L. A. (2010). Factors affecting wound healing. Journal of Dental Research, 89(3), 219–229.
Holick, M. F. (2007). Vitamin D deficiency. New England Journal of Medicine, 357(3), 266–281.
Jabbar, A., Ingoe, L., Pearce, S., Zaman, A., & Razvi, S. (2021). Thyroxine treatment for subclinical hypothyroidism: a clinical practice guideline. European Thyroid Journal, 10(2), 152–162.
Mohamad, N. V., Soelaiman, I. N., & Chin, K. Y. (2016). A concise review of testosterone and bone health. Clinical Interventions in Aging, 11, 1317–1324.
Santoro, N., Roeca, C., & Peters, B. A. (2021). The menopause transition: Signs, symptoms, and management options. The Journal of Clinical Endocrinology & Metabolism, 106(1), 1–15.
Schaffer, C. J., Nanney, L. B., & Stecenko, A. A. W. H. (2016). Wound healing. In Fitzpatrick’s Dermatology in General Medicine (9th ed.). McGraw-Hill.
Yoo, J. Y., Groer, M., Dutra, S. V. O., & Sarkar, A. (2020). Gut microbiota and immune system interactions. Microorganisms, 8(10), 1587.

SEO Tags: Hormone Replacement Therapy, BHRT, Bioidentical Hormones, Menopause, Andropause, Integrative Chiropractic Care, Functional Medicine, Testosterone, Estradiol, Thyroid Health, Dr. Alex Jimenez, Pellet Therapy, Subclinical Hypothyroidism, Ferritin, Vitamin D, Patient Education, Clinical Workflow, Case Study, Pellet Insertion, Wound Healing, Langer’s Lines, Trocar Technique, Musculoskeletal Health, Inflammation, El Paso Chiropractor

April 24, 2026

Evidence-Based Integrative Hormone Care

Endometrial Health, Thrombosis Safety, Pain, Hair, and Patient-Centered Systems

Abstract

In this educational post, I walk you through how I design and deliver patient-centered, evidence-based care across hormones, endometrial health, thrombosis risk, pain and musculoskeletal function, hair physiology, and practical clinical systems. I explain the physiology behind each decision, why route and dose matter for estrogen, progesterone, and testosterone, how we interpret endometrial thickness and select biopsy methods, and why non-oral estradiol reduces the risk of venous thromboembolism. I share protocols to prevent testosterone-induced erythrocytosis, guide fertility counseling, and manage acne and hair shedding with a stable pharmacokinetic profile. Throughout, I show how integrative chiropractic care strengthens autonomic regulation, venous and lymphatic return, pelvic mechanics, and pain modulation, improving tolerance and outcomes. You will see the latest findings from leading researchers and how I apply them, visit by visit, with systems that keep patients supported and safe.

Introduction: My Integrative Approach to Complex Care

I am Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. In daily practice, I manage patients whose needs span endocrinology, gynecology, hematology, cardiometabolic health, neuromuscular pain, and performance. Excellent outcomes rarely depend on a single intervention; they come from a reliable care system: clear intake, structured follow-up, proactive side-effect management, and consistent communication. When we blend modern research methods with hands-on chiropractic-informed strategies and functional medicine principles, patients gain clarity, safety, and momentum.

What follows is the step-by-step journey I use to:

Align care with patient priorities through goal-concordant planning.
Choose hormone routes and doses that fit physiology and risk.
Interpret endometrial health with ultrasound, histology, and modern molecular adjuncts.
Reduce thrombosis risk using non-oral estrogen and careful testosterone monitoring.
Stabilize pain, sleep, and autonomic balance with integrative chiropractic care.
Manage hair health, acne, and metabolic drift with steady-state pharmacokinetics.
Build systems—checklists, schedules, micro-interventions—that make care predictable.

Core Patient-Centered Workflow: Systems that Prevent Dropout and Improve Safety

Patients judge success by whether we address their top three priorities. My system ensures those priorities drive decisions and scheduling:

Identify and document the patient’s top three goals at the start.
Pre-schedule next visits so that at least 90% leave with follow-up in place.
Use a structured side-effect checklist to detect issues early.
Apply communication scripts and provisional bookings to protect continuity.
Set a follow-up cadence: every 4–6 weeks for early stabilization, then extend based on lab and symptom stability.

Why this works: When patients can see the plan—and we guide them through it—adherence rises, and avoidable complications fall. Momentum prevents the stop-start patterns that lead to frustration, missed labs, and poor outcomes. My clinic observations at ChiroMed consistently show that pre-scheduled follow-ups and clear written care plans raise satisfaction and reduce detours (Chiromed.com; Jimenez, LinkedIn).

Integrative Chiropractic Care: The Physiologic Amplifier

Integrative chiropractic is not an add-on; it is a physiological amplifier. Hormones shift sleep, mood, vascular tone, and pain perception. When we optimize neuromuscular balance and autonomic function, patients tolerate medication better and experience smoother relief.

Key pillars and why they matter:

Autonomic regulation: Gentle spinal adjustments and soft-tissue work modulate the sympathetic-parasympathetic balance. Improved vagal tone supports sleep, digestion, and inflammatory resolution—critical when initiating progesterone, which exerts GABAergic sedative effects.
Pelvic mechanics and circulation: Restoring lumbosacral and pelvic girdle motion improves venous and lymphatic outflow, reducing pelvic congestion, cramping, and pressure that co-occur with abnormal bleeding.
Pain modulation: Manual therapy stimulates mechanoreceptors that dampen nociception and hyperalgesia. Fluctuating estrogen and progesterone can alter pain thresholds; chiropractic helps stabilize responses.
Exercise prescriptions: Low-impact strength, mobility, and breathing drills improve diaphragmatic tone, sleep quality, and recovery.

Clinical observations from my practice show that combining evidence-based medical therapy with chiropractic-guided plans produces better sleep, fewer pain flares, and a more stable mood (Chiromed.com; Jimenez, LinkedIn). This multimodal synergy creates sustainable improvement.

Progesterone Physiology and Practical Use: Sleep, Mood, and Endometrial Stability

Progesterone is central to managing abnormal uterine bleeding, sleep disturbances, and perimenopausal symptoms. Physiologically, progesterone:

Drives endometrial differentiation to the secretory state, countering estrogen’s proliferative effect.
Acts via neurosteroid metabolites like allopregnanolone on GABA-A receptors, producing anxiolytic and sedative effects that improve sleep.
Modulates inflammatory cytokine signaling, potentially reducing pelvic pain in inflammatory endometrial states.

Clinical indications:

Abnormal uterine bleeding when estrogen is relatively unopposed.
Sleep support during perimenopause and menopausal transitions.
Endometrial protection as part of estrogen therapy.

Formulation and dosing strategy:

Oral micronized progesterone (e.g., 200 mg at bedtime): Predictable systemic absorption and helpful somnolence when sleep support is desired. First-pass metabolism varies among patients, and some experience grogginess; we titrate dose and timing to align with goals.
Sublingual/buccal troches (e.g., 200 mg): Rapid absorption and reduced first-pass metabolism; less somnolence, preferred when daytime clarity is essential.
Quality matters: High-quality compounded formulations minimize excipient variability and allergen exposure (e.g., oil-based excipients), resulting in more consistent bioavailability and fewer erratic symptom cycles.

Why details matter: Align pharmacodynamics with patient goals. If sleepiness is helpful, we leverage it. If daytime function is critical, we shift to non-sedating schedules or formulations. Consistency builds confidence in the dose-response and reduces symptom cycling.

Endometrial Health: Thickness, Imaging, and Biopsy Decisions

The endometrium is highly responsive to hormonal balance. Ultrasound-measured endometrial thickness and tissue patterns guide risk stratification and biopsy decisions:

Thickness thresholds: In postmenopausal contexts, a properly timed ≤4 mm thickness often indicates a low immediate risk of endometrial carcinoma, per typical guidelines, when history and symptoms align.
Patterns and heterogeneity: Focal masses, polyps, or heterogeneous echotexture raise suspicion for polyps, hyperplasia, or neoplasia.
Biopsy selection:
- Tissue biopsy remains the gold standard for histologic confirmation when imaging or symptoms indicate focal pathology or possible hyperplasia/cancer.
- Liquid biopsy is an evolving adjunct that detects circulating tumor signals, promising but complementary to tissue histology for endometrial disease.

Clinical reasoning: If ultrasound shows benign features and low thickness while symptoms stabilize, the immediate cancer risk is low for that episode. Persistent or recurrent bleeding demands follow-through, regardless of a single reassuring test. We educate patients that good biopsy results are not the end of monitoring; symptoms still drive surveillance.

Hormone Routes and Thrombosis Safety: What Leading Research Shows

Route choice changes risk. Modern cohort analyses and meta-analytic data consistently demonstrate that oral estrogen induces hepatic synthesis of coagulation proteins, whereas transdermal estradiol bypasses the liver and is associated with neutral venous thromboembolism (VTE) risk in many populations.

What the data show:

Oral estrogen upregulates coagulation factors (e.g., factor VII and fibrinogen), thereby increasing VTE risk in some groups.
Transdermal estradiol has minimal effects on coagulation markers and is associated with neutral VTE profiles in large observational cohorts (Canonico et al., 2016; Vinogradova et al., 2019).
Micronized progesterone appears to have a neutral effect on VTE risk compared with certain synthetic progestins, which can increase risk when combined with oral estrogens (Stute et al., 2016).

Why I prefer non-oral starts:

For patients with prior clots, thrombophilias, or perioperative risk, non-oral estradiol protects hepatic coagulation balance.
Bedtime micronized progesterone synergizes with sleep architecture via GABAergic pathways.
Testosterone is best managed with carefully titrated non-oral options to avoid supraphysiologic peaks that can drive erythrocytosis.

Testosterone, Erythropoiesis, and Hematocrit: Mechanisms and Monitoring

Testosterone stimulates erythropoiesis by increasing erythropoietin (EPO) sensitivity and marrow response. Elevated hematocrit increases blood viscosity, especially above 52–54%, interacting with dehydration, smoking, and sleep apnea to raise risk.

My monitoring plan:

Baseline CBC, then at 3 months, 6 months, and every 6–12 months.
If hematocrit exceeds thresholds (e.g., 52–54%), lower the dose, extend intervals, evaluate for sleep apnea and hydration status, and consider therapeutic phlebotomy if indicated (Corona et al., 2014; Pastuszak et al., 2015).

Why dose matters: Erythrocytosis is dose-related and reversible. The goal is to maintain energy, libido, and mood benefits while keeping hematocrit within safe limits. We also coordinate with nephrology in CKD contexts to balance anemia management with hemodynamic safety.

Fertility and the Gonadal Axis: Counseling and Alternatives

Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal (HPG) axis, lowering LH/FSH, reducing intratesticular testosterone, and decreasing sperm production. This effect is typically reversible over months after cessation.

Counseling steps:

Avoid starting testosterone when planning conception.
Consider HCG or SERMs under careful supervision to maintain intratesticular testosterone and support spermatogenesis.
Set expectations: recovery of sperm count can take up to 12 months, depending on baseline sperm count and the duration of suppression.

Stable Pharmacokinetics: Why Smooth Curves Beat Spikes

Short-acting hormonal modalities often create spike-and-crash profiles: transient peaks drive acne, irritability, fluid shifts, and receptor sensitization; troughs lead to fatigue and reduced efficacy. Longer-acting or split-dose strategies produce smoother curves with fewer adverse events.

Practical strategies:

Use smaller, more frequent injections to reduce peaks and troughs.
Prefer steady transdermal systems with consistent absorption.
Time labs relative to dosing to capture true troughs and peaks for precise titration (Pilz et al., 2015; Corona et al., 2022).

Clinical observation: Patients report dramatic improvements early after a large injection, then crash by day six. Dividing doses stabilizes energy and reduces acne. My ChiroMed experiences show better adherence and satisfaction when we minimize peaks and synchronize dosing with lifestyle and movement plans (Chiromed.com; Jimenez, LinkedIn).

Hair Physiology, DHT, and Shedding: Understanding the Transition

Hair cycles include anagen (growth) and telogen (shedding). When metabolism reactivates with hormone optimization, shedding can transiently increase as telogen hairs release to make room for new anagen growth. This is a transition, not failure.

Key points:

DHT (via 5-alpha-reductase) miniaturizes hair follicles in genetically susceptible individuals; testosterone itself does not directly cause hair loss without conversion to DHT and susceptibility.
Assess DHT, thyroid status, ferritin, vitamin D, and family history of androgenetic alopecia.
Manage DHT-driven loss with 5-alpha-reductase modulation when indicated, alongside scalp microcirculation support and mitochondrial health.

Supportive measures:

Nutritional optimization: protein, iron stores, B vitamins, and vitamin D near personalized targets.
Scalp care: minoxidil, gentle topicals for women, light-based therapies for men with sensitive skin.
Integrative strategies: diaphragmatic breathing and ribcage mobility to enhance perfusion and nitric oxide bioavailability; consider spermidine to support autophagy and follicle energetics (Holick, 2017; Eisenberg et al., 2019; Lanzillo et al., 2020).

Acne, Aromatization, and Dose Smoothing

Sharp androgen peaks stimulate sebaceous activity and keratinocyte proliferation. Smoother dosing profiles reduce acne. If aromatization spikes estradiol, we adjust testosterone dose before adding aggressive aromatase inhibition to protect bone and lipids. Skin protocols differ by sex and sensitivity:

Women: gentle salicylic acid; escalate to retinoids if needed; align with dose smoothing.
Men: if salicylic acid irritates, consider intense pulsed light (IPL), and prioritize pharmacokinetic smoothing.

Hypertension and Beta Blockers: Modern First-Line Reasoning

Beta blockers are no longer first-line for uncomplicated hypertension without compelling indications. Contemporary evidence favors thiazides, ACE inhibitors/ARBs, or calcium channel blockers for primary hypertension due to better stroke risk reduction and metabolic profiles (Wiysonge et al., 2017; Messerli et al., 2018).

What I do:

Reassess long-standing beta blocker use; confirm indications (post-MI, arrhythmias, heart failure).
Transition to guideline-preferred agents when appropriate.
Use chiropractic care to improve baroreflex sensitivity, breathing mechanics, and stress modulation; patients often experience more stable blood pressure variability along with movement prescriptions.

Infection Control and Post-Procedure Safety: Culture-Guided Action

Early post-procedure windows (days 7–14) are critical for catching wound complications before abscess formation. I schedule a 7-day in-person check and coach patients to send clear photos of their wounds if changes occur.

Why culture first:

Culture-guided therapy allows the use of narrow-spectrum antibiotics tailored to susceptibility, reduces resistance, and prevents symptom chasing.
If an abscess is present, perform incision and drainage; antibiotics alone cannot treat closed purulent collections (Stevens et al., 2014).
Build pre-op checklists (e.g., MSSA/MRSA screening and decolonization) and audit workflow compliance.

Chiropractic role:

Gentle autonomic regulation via breathing training and low-load mobility supports microcirculation and healing.
Regional joint mobilization (when cleared) assists lymphatic and venous return, reducing edema and discomfort.

Practical Medication Transitions: Sertraline and Tricyclics

Beyond hormones, careful pharmacology matters:

Sertraline titration should be gradual to avoid activation (anxiety, insomnia). Split dosing can moderate peak plasma concentrations.
Tricyclics require attention to CYP450 interactions and QT risk; space timing to avoid peak overlap and monitor EKG when indicated.
Reinforce sleep hygiene; poor sleep magnifies activation side effects and destabilizes autonomic tone.

Micro-Interventions and Clinical Checklists: Making Care Stick

High-performing clinics rely on checklists and short, repeatable micro-interventions:

Pre-procedure: screening for MSSA/MRSA, consent, wound care education, and scheduling the 7-day check.
Post-procedure: early re-check, cultures if draining, photo documentation, pain/function scoring.
Hormone transitions: lab scheduling, side-effect diaries, sleep-hygiene reinforcement, communication templates for primary care.

Five-minute interventions—breathing drills, posture resets, movement reminders—stacked across the week build habits, reduce pain, and support adherence without derailing clinic flow.

Putting It Together: A Patient Journey Example

I saw a patient for a scheduled 7-day post-procedure check. They reported mild redness and warmth:

We compared local temperature and tenderness to adjacent tissue, noted light serous drainage, and obtained a wound culture before antibiotics.
We set a 48–72 hour follow-up aligned to culture processing and documented their top priorities (pain reduction, return to work, and cosmetic healing).
Simultaneously, we planned a low-dose bridging approach for their transition from testosterone injections to a steadier regimen and aligned sleep and movement protocols (calf-pump activity and diaphragmatic breathing).
Result: targeted antibiotics matched the culture, swelling resolved, and the hormone transition proceeded with minimal side effects. Within four weeks, they met their top priorities and returned to training with improved energy and mood.

Why Integrative Chiropractic Belongs in This Care

The pelvis and spine are not isolated constructs; they interact with hormonal states, autonomic tone, and pain sensitivity. By improving joint mechanics, reducing muscle guarding, and supporting a parasympathetic shift, integrative chiropractic enhances the body’s ability to accommodate medication effects and heal.

Patients commonly report:

Better sleep onset and maintenance.
Reduced pelvic pressure and cramping.
Fewer anxiety flares during dose changes.
Enhanced energy and recovery.

My clinical observations reflect that this multimodal approach is both scientifically sensible and practically effective (Chiromed.com; Jimenez, LinkedIn).

Key Takeaways You Can Use Today

Prefer non-oral estradiol to minimize the impact on coagulation and VTE risk.
Use micronized progesterone at bedtime for endometrial protection and GABAergic sleep support.
Monitor hematocrit diligently with testosterone; adjust dose and intervals, assess OSA, hydration, and consider therapeutic phlebotomy when needed.
Stabilize pharmacokinetics: avoid short-acting spikes; divide doses for smoother curves.
Manage DHT thoughtfully; check thyroid and ferritin for hair health.
Employ culture-guided infection management; schedule a 7-day post-procedure check.
Build systems: checklists, side-effect diaries, pre-scheduled follow-ups, and micro-interventions.
Integrate chiropractic care to optimize autonomic regulation, venous return, pelvic mechanics, and pain modulation.

References

Canonico, M., Plu-Bureau, G., Lowe, G. D. O., & Scarabin, P. Y. (2016). Transdermal estrogen and venous thromboembolism risk in postmenopausal women: evidence overview. Maturitas.
Vinogradova, Y., Coupland, C., & Hippisley-Cox, J. (2019). Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch database. BMJ.
Stute, P., Wildt, L., & Neulen, J. (2016). Micronized progesterone and risk profile compared to synthetic progestins. Journal of Public Health.
Corona, G., et al. (2014). Testosterone therapy and erythrocytosis: mechanisms and management. The Journal of Sexual Medicine.
Pastuszak, A. W., et al. (2015). Testosterone therapy, hematocrit changes, and thrombotic risk: clinical outcomes. Andrology.
Pilz, S., et al. (2015). Testosterone therapy: metabolic and cardiovascular considerations. Nature Reviews Endocrinology.
Corona, G., et al. (2022). Androgen therapy updates: safety, delivery, and outcomes. Journal of the Endocrine Society.
Wiysonge, C. S., Bradley, H. A., Volmink, J., et al. (2017). Beta-blockers for hypertension. Cochrane Database of Systematic Reviews.
Messerli, F. H., Bangalore, S., Bavishi, C., & Rimoldi, S. F. (2018). Beta blockers in hypertension: their role and limitations. Current Hypertension Reports.
Stevens, D. L., et al. (2014). Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clinical Infectious Diseases.
Eisenberg, T., Abdellatif, M., et al. (2019). Spermidine and health: autophagy and cardiometabolic benefits. Journal of Cellular and Molecular Medicine.
Holick, M. F. (2017). Vitamin D and hair: dermatologic perspectives. Nature Reviews Endocrinology.
Lanzillo, R., et al. (2020). Nitric oxide signaling in endocrine and metabolic regulation. Metabolism.
Jimenez, A. (n.d.). ChiroMed—Clinical observations and integrative outcomes.
Jimenez, A. (n.d.). Dr. Alexander Jimenez—Professional profile and clinical insights.

April 23, 2026

Bioidentical Hormones Benefits Overview for Patient Wellness

Transform your health with bioidentical hormones and elevate patient wellness through natural hormonal balance.

Navigating Hormonal Health: An Integrative Approach to Wellness

In this educational post, I will explore the complex and fascinating world of hormone optimization from an integrative perspective. Drawing upon the latest evidence-based research and my clinical experience, we will delve into the nuances of hormone replacement therapy (HRT), including the transition from traditional birth control to bioidentical hormones. We will discuss the physiological basis for common symptoms like menstrual migraines and perimenopausal anxiety, and I’ll share specific protocols for managing these conditions effectively. Furthermore, we will examine the crucial role of nutrition, sleep, and targeted supplementation in supporting hormonal balance. This discussion will also cover advanced testing methodologies and address common concerns, such as the use of topical estrogens and the safety of HRT in various patient populations. Finally, I will explain how integrative chiropractic care is an essential component of this holistic treatment model, helping to restore overall physiological function and enhance the body’s innate healing capabilities.

Foundations of Bioidentical Hormone Replacement: Source and Application

As a practitioner dedicated to functional and integrative medicine, I frequently encounter a question from both patients and fellow clinicians about the origins of the hormones we use. Specifically, “What is the source of the bioidentical hormones, like estrogen, used in therapy?”
This is a fantastic and crucial question. The bioidentical estradiol and progesterone we use in compounded therapies are derived from plant sources. The starting molecule, diosgenin, is extracted from wild yams. It is important to note that this is not the sweet potato but the true yam plant. Diosgenin is a phytosteroid, a plant-based steroid, with a molecular structure that makes it an ideal precursor. In a compounding pharmacy, skilled chemists modify this diosgenin molecule, altering its chemical structure to create 17-beta estradiol and progesterone. These resulting hormones are termed “bioidentical” because they are molecularly identical to the hormones our bodies produce naturally. This molecular mimicry is key to their efficacy and safety profile, as the body’s cellular receptors recognize and utilize them just as they would endogenous hormones.
Historically, some hormone precursors were derived from soy, but the industry has largely shifted to yam-based sources to avoid potential issues related to soy sensitivities and phytoestrogenic effects.
Another common clinical question is about layering different types of therapies. For instance, can a topical cream for enhancing libido be used in conjunction with hormone pellets?

Yes, absolutely. You can layer these therapies. A topical cream, which might contain a blend of ingredients such as testosterone, oxytocin, or other compounds designed to increase local blood flow and nerve sensitivity, works through a different mechanism and pathway than systemic hormone pellets do.
The pellets provide a steady, baseline level of hormones (like testosterone and estradiol) systemically, which addresses the root cause of low libido from a physiological standpoint.
The topical cream provides targeted, localized support. Because it’s utilized differently, there’s no contraindication; in fact, this multimodal approach can be highly effective for patients with refractory libido issues.

Navigating the Transition from Birth Control to BHRT

A significant part of my practice involves helping women transition from synthetic hormonal birth control to bioidentical hormone replacement therapy (BHRT). The conventional practice of keeping women on birth control pills until age 51 and then abruptly stopping is outdated and, frankly, unsafe.

The Risks of Prolonged Oral Contraceptive Use

Birth control pills are designed for one primary purpose: contraception. Once a woman no longer requires them for preventing pregnancy—perhaps due to a tubal ligation, having an IUD, or a vasectomized partner—she should not remain on them for other reasons like managing menstrual migraines or endometriosis. Synthetic hormones in oral contraceptives carry significant risks, including:

Deep Vein Thrombosis (DVT)
Pulmonary Embolism (PE)
Stroke

In my clinical practice and from collaborating with my colleagues, I have seen devastating cases of women in their 40s with no other underlying health issues suffering major strokes directly linked to their oral contraceptive use. While the risk-benefit ratio may be acceptable for a 20-year-old (where the risk of a DVT from pregnancy is comparable to the risk from the pill), this ratio shifts dramatically as a woman ages and no longer faces the risk of pregnancy.

The Transition Protocol

So, how do we safely transition a patient? The key is to determine her true menopausal status, which is masked by the synthetic hormones in birth control pills.

Initial Bloodwork: I start by testing the Follicle-Stimulating Hormone (FSH) level while the patient is still on the pill.
- An FSH of 10 mIU/mL or greater strongly suggests she is in the menopausal transition.
- An FSH of 5 mIU/mL or less indicates she is likely still premenopausal.
The “Gray Zone”: If the FSH falls into the intermediate range (e.g., 6-9 mIU/mL), clarity is needed. I will have the patient stop the birth control pill for approximately three weeks. During this washout period, it’s crucial to use a reliable barrier method of contraception, like condoms.
Confirmatory Testing: After the three-week washout, I retest the FSH. A level of 23 mIU/mL or higher is a definitive indicator of menopause.
Seamless Transition: Once menopause is confirmed, the transition can happen literally overnight. She stops the pill and begins her personalized BHRT protocol, which typically includes bioidentical estrogen and testosterone (often via pellets) and oral micronized progesterone at bedtime.

For a perimenopausal patient, meaning she hasn’t been without a cycle for a full 12 months, a more cautious approach is warranted. I would start with a lower dose of estrogen, such as 6 mg, to avoid inducing bleeding. We can always titrate the dose upwards based on her symptoms and follow-up lab work in six weeks. It’s always easier to add more hormone than to deal with the consequences of overdosing.

The Critical Role of Integrative Chiropractic Care

In my practice, where I hold credentials as both a chiropractic physician and an advanced practice nurse, I have observed the profound impact of combining hormonal and metabolic treatments with physical medicine. Integrative chiropractic care is not just about addressing back pain; it is a foundational element of restoring systemic health.
The nervous system is the master controller of the body, directly influencing the endocrine system via the hypothalamic-pituitary-adrenal (HPA) axis. Structural misalignments in the spine, known as vertebral subluxations, can create nerve interference, disrupting the delicate communication between the brain and the body’s glands, including the ovaries, adrenals, and thyroid.

Restoring Neurological Function: Chiropractic adjustments correct these subluxations, reducing nerve interference and optimizing HPA axis function. This can help normalize cortisol production, which in turn reduces the “theft” of pregnenolone (the mother hormone) for cortisol synthesis, leaving more available to produce progesterone and other vital sex hormones.
Improving Blood Flow: Adjustments improve circulation to the pelvic organs and endocrine glands, ensuring they receive the oxygen and nutrients needed for optimal function.
Reducing Systemic Stress: The physical act of a chiropractic adjustment has been shown to decrease sympathetic (fight-or-flight) tone and increase parasympathetic (rest-and-digest) activity. This physiological shift is crucial for hormonal balance, as chronic stress is a major disruptor of the endocrine system.

By integrating chiropractic care, we are not just treating symptoms; we are addressing the underlying structural and neurological dysfunctions that contribute to hormonal imbalance, thereby creating a more robust and lasting foundation for wellness.

Addressing Specific Conditions: Anxiety, Migraines, and Sleep

Perimenopausal Anxiety and PMS

Severe anxiety and mood swings, particularly those linked to the menstrual cycle (PMS/PMDD), are often rooted in hormone fluctuations. While testosterone replacement is a cornerstone for mood stabilization, oral micronized progesterone is a powerful tool, especially for anxiety.
Progesterone’s calming effect comes from its metabolite, allopregnanolone, which acts as a positive allosteric modulator of the GABA-A receptor in the brain. GABA is the primary inhibitory neurotransmitter, and enhancing its function promotes relaxation and reduces anxiety.

Nighttime Dosing: For sleep disturbances and generalized anxiety, I typically prescribe oral progesterone at bedtime.
Daytime Anxiety: For patients with severe daytime anxiety, a small dose of 25 mg of oral progesterone can be remarkably effective. I have seen this strategy transform the lives of patients, including young women in their teens with debilitating hormonal fluctuations, allowing them to avoid psychiatric medications.

Menstrual Migraines

Menstrual migraines are triggered by the sharp drop in estrogen that occurs right before the onset of menses. The treatment is elegantly simple and highly effective.

The Protocol: I prescribe a very low dose of topical estrogen (e.g., a small dab of estradiol cream) to be applied daily for the seven days leading up to the expected start of the period.
The Mechanism: This small amount of estrogen is just enough to create a “trough” level, preventing the precipitous drop that triggers the migraine cascade. It’s a drop in the bucket in terms of total monthly estrogen exposure and is not enough to disrupt the natural cycle or require opposing progesterone. This simple intervention has a success rate of over 95% in my clinical experience.

Sleep, Growth Hormone, and the Modern Epidemic

Sleep is non-negotiable for hormonal health. The most critical period for hormone production is between 11:00 PM and 2:00 AM. During this deep sleep window, the body produces growth hormone (GH), which in turn stimulates the liver to produce Insulin-like Growth Factor 1 (IGF-1).
I see a concerning trend in younger patients. They are staying up until 2:00 AM on their phones, bathed in blue light that suppresses melatonin production. This lifestyle completely obliterates their deep sleep cycle. Consequently, they are not producing adequate growth hormone, their IGF-1 levels are collapsing, and their entire hormonal cascade suffers. This is often compounded by a diet high in sugar and processed foods. The result is a generation of young people with the hormonal profiles of much older individuals.
My approach involves a comprehensive lifestyle overhaul:

Dietary Intervention: An organic, whole-foods diet, eliminating sugar and processed foods.
Supplementation: A targeted regimen including a high-quality B-complex, Vitamin D, iodine, and probiotics.
Sleep Hygiene: Strict sleep schedules and eliminating screen time before bed.
Chiropractic Care: To reduce systemic stress and improve neurological function.

Advanced Topics and Clinical Pearls

Topical Estrogen on the Face

Some patients ask about using topical estrogen on their faces for cosmetic benefits. While estrogen does improve skin elasticity and collagen production, applying a standard BHRT estrogen cream directly to the face is problematic. The facial skin is highly vascular, and this application would lead to significant systemic absorption, driving serum estrogen levels dangerously high. A much safer alternative is to use a compounded cream containing estriol (E3), the weakest of the three main estrogens, which provides local benefits with minimal systemic absorption.

Testing and Monitoring

Accurate testing is paramount. For thyroid hormones, I prefer using Liquid Chromatography-Mass Spectrometry (LC-MS). It is more precise than radioimmunoassay (RIA), which can be subject to cross-reactivity with substances like biotin, leading to falsely elevated estradiol results. When testing T3, it’s essential to know when the patient took their last dose of thyroid medication, as a recent dose can cause a transient spike in levels.

Interacting with Other Medical Professionals

Unfortunately, there can be resistance from practitioners in other specialties, such as oncology or cardiology, who may not be up to date with the literature on BHRT. The best approach is education and providing data. Dr. Rebecca Glaser, a leading researcher, has an excellent open-access website that collates studies on the safety of testosterone therapy, even in breast cancer survivors. Providing this evidence-based literature to concerned colleagues can help bridge the knowledge gap and ensure continuity of care for our patients.
Hormone optimization is a journey that requires a personalized, evidence-based, and integrative approach. By addressing the biochemical, structural, and lifestyle factors that influence hormonal health and by using tools like BHRT and integrative chiropractic care, we can empower our patients not just to manage symptoms but to achieve true vitality and wellness.

References

Glaser, R., & Dimitrakakis, C. (2013). Testosterone therapy in women: Myths and misconceptions. Maturitas, 74(3), 230–234. https://doi.org/10.1016/j.maturitas.2013.01.003
MacGregor, E. A. (2018). Menstrual migraine. Current Opinion in Neurology, 31(3), 299–304. https://doi.org/10.1097/WCO.0000000000000557
Schüssler, P., Kluge, M., Yassouridis, A., Dresler, M., Held, K., Zihl, J., & Steiger, A. (2008). Progesterone reduces wakefulness in sleep EEG and does not affect cognition in healthy postmenopausal women. Psychoneuroendocrinology, 33(8), 1124–1131. https://doi.org/10.1016/j.psyneuen.2008.05.013
Stephenson, K., & Neuenschwander, P. F. (2012). The use of bioidentical hormone replacement therapy (BHRT) in the treatment of perimenopausal and menopausal symptoms. Integrative Medicine: A Clinician’s Journal, 11(5), 40–43. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4593925/

SEO Tags: bioidentical hormones, integrative chiropractic, hormone replacement therapy, Dr. Alexander Jimenez, BHRT, perimenopause, menopause, testosterone therapy, oral progesterone, menstrual migraines, FSH testing, transitioning from birth control, functional medicine, HPA axis, vertebral subluxation, estriol, sleep and hormones

April 23, 2026

Delayed Car Accident Symptoms: Hidden Injuries

Red Flags and How Integrative Chiropractic Care Can Help

A car accident does not always cause pain right away. Many people walk away from a crash thinking they are lucky, only to wake up the next day with a pounding headache, neck stiffness, back pain, abdominal discomfort, or trouble concentrating. This happens more often than people realize. In the hours after a collision, adrenaline and shock can hide pain. As the body calms down, inflammation increases, muscles tighten, and injured tissues begin sending stronger warning signals (Sirota Chiropractic, n.d.; The Neck and Back Clinics, n.d.).

That is why delayed symptoms after a crash should never be ignored. What seems like mild soreness can turn out to be whiplash, a concussion, nerve irritation, soft tissue damage, or even internal bleeding. At a recovery-focused clinic like ChiroMed, the goal is not just to chase symptoms. The goal is to identify the cause of the pain, restore healthy movement, reduce inflammation, and help prevent long-term problems through integrative, non-invasive care when it is safe and appropriate to do so (Tarpon Total Healthcare, n.d.; Hudak, n.d.).

Why do delayed symptoms happen after a crash

Right after an accident, the body releases stress hormones that help a person stay alert. This survival response is useful in the moment, but it can also mask pain. Hours later, swelling builds, muscles tighten, and irritated nerves begin to send clearer signals. That is when symptoms often appear (Dr. Sirota, n.d.; Stumpff Chiropractic, n.d.).

Delayed symptoms are common with:

Whiplash
Soft tissue sprains and strains
Disc irritation
Nerve compression
Mild traumatic brain injury
Internal injuries
Emotional trauma (Burns, Bryant, Cox, Rockefeller & Durkin, P.A., n.d.; Total Vitality Medical Group, n.d.)

This delayed pattern is one reason early evaluation matters. A person may feel stable at first and still have a real injury that needs attention.

The most common hidden symptoms to watch for

Headaches that do not go away

A headache after a car accident may come from muscle tension, joint irritation in the neck, a concussion, or a more serious injury. If the headache keeps getting worse, comes with dizziness, or is accompanied by confusion or vision changes, it needs prompt medical attention (Chambers Medical, n.d.; Dr. Derek Day Chiropractic, n.d.).

Headaches may be linked to:

Whiplash
Concussion
Neck muscle strain
Ligament injury
Stress and trauma after the accident (Chambers Medical, n.d.; Lorfing Law, n.d.)

At ChiroMed, headaches after an accident would not be treated as a small complaint. They would be viewed as a signal that a more thorough evaluation may be needed to determine whether the source is musculoskeletal, neurological, or requires emergency referral.

Neck pain and stiffness

Neck pain is one of the most common delayed symptoms after a crash. A sudden forward-and-back motion can strain muscles, ligaments, discs, and joints in the cervical spine. This is often called whiplash. Some people feel only mild stiffness at first, but over the next day or two, turning the head may become difficult and painful (The Neck and Back Clinics, n.d.; South Atlanta Injury Lawyers, n.d.).

Warning signs include:

Stiffness when turning the head
Pain at the base of the skull
Shoulder tightness
Reduced range of motion
Muscle spasms
Pain that travels into the arms (The Neck and Back Clinics, n.d.; Total Vitality Medical Group, n.d.)

These symptoms should not be ignored because untreated whiplash can lead to chronic pain, poor posture, and ongoing movement problems.

Back pain and limited mobility

Back pain after a collision may involve the muscles, spinal joints, discs, or ligaments. Sometimes pain starts as soreness and later becomes sharp or radiating. It may affect the neck, mid-back, or low back. Even a low-speed crash can create enough force to disturb spinal mechanics and inflame soft tissue (McIntyre Law, n.d.; Smith & Hassler, n.d.).

People should pay close attention to:

Pain when bending or twisting
Stiffness when standing up
Pain that worsens with sitting
Muscle guarding
Reduced flexibility
Trouble walking normally (McIntyre Law, n.d.; Elledge Chiropractic, n.d.)

This is where integrative chiropractic care may help once serious emergencies have been ruled out. Restoring motion, lowering inflammation, and improving alignment can reduce the chance that a short-term injury becomes a long-term problem.

Numbness, tingling, and pins and needles

Pins and needles in the arms, hands, legs, or feet may point to nerve irritation or compression. Swelling, disc injury, or joint dysfunction can place pressure on nearby nerves after a crash. A person may also notice weakness, burning, or a strange, crawling sensation (PLW Law, n.d.; The Neck and Back Clinics, n.d.).

These are not symptoms to ignore. Numbness and tingling can mean the nervous system is involved. A careful exam is important to decide whether the problem is coming from the neck, back, or another area of injury (McIntyre Law, n.d.; On My Side, n.d.).

Abdominal pain, swelling, or bruising

Abdominal pain after a crash can be especially serious. It may be caused by seatbelt trauma, bruising, organ injury, or internal bleeding. Unlike muscle soreness, internal injuries can worsen quickly and may not always show clear signs right away (1800 Law 1010, n.d.; Dr. Derek Day Chiropractic, n.d.).

Emergency warning signs include:

Abdominal swelling
Deep bruising
Nausea or vomiting
Dizziness
Fainting
Severe tenderness
Blood in stool or vomit (1800 Law 1010, n.d.; On My Side, n.d.)

These symptoms require emergency medical care. Chiropractic care is not a substitute for urgent hospital evaluation in cases like these.

Emotional distress and mental fog

A crash can affect both the body and the mind. Some people feel fine physically but begin to notice anxiety, irritability, poor sleep, mood swings, flashbacks, or trouble focusing in the days after the accident. Others feel emotionally numb at first and then become overwhelmed later (Ruhmann Law Firm, n.d.; Keller & Keller, n.d.).

These symptoms matter because emotional trauma can affect healing, sleep, pain levels, and daily function. Stress may also increase muscle tension and worsen physical symptoms. A full recovery plan should take emotional health seriously, not treat it as an afterthought.

Red flags that need immediate medical care

Some delayed symptoms indicate conditions that require urgent or emergency evaluation. These include:

Severe or worsening headache
Dizziness or fainting
Confusion or memory loss
Slurred speech
Sudden weakness
Numbness that is spreading
Severe neck or back pain
Loss of bladder or bowel control
Abdominal swelling or severe pain
Vomiting
Trouble breathing
Chest pain (PLW Law, n.d.; Chambers Medical, n.d.; On My Side, n.d.)

At ChiroMed, these red flags would lead to immediate referral for emergency or medical evaluation. Good integrative care starts with knowing when a condition is outside the safe scope of conservative treatment.

How an integrative chiropractic clinic can help after a crash

Once serious injuries have been ruled out or are being co-managed, an integrative chiropractic clinic can help guide recovery in a focused and non-invasive way. The purpose is not just pain relief. The purpose is to improve movement, reduce stress on injured tissues, and support healing before dysfunction becomes chronic (Tarpon Total Healthcare, n.d.; Hudak, n.d.).

A post-accident evaluation may include:

A detailed history of the crash
Review of delayed symptoms
Range of motion testing
Orthopedic and neurological screening
Posture and spinal assessment
Soft tissue evaluation
Referral for imaging when needed (Hudak, n.d.; Dr. Sirota, n.d.)

Depending on the case, conservative care may include:

Gentle chiropractic adjustments
Soft tissue therapy
Myofascial release
Mobility work
Corrective exercise
Postural support
Home recovery guidance
Progress monitoring (Tarpon Total Healthcare, n.d.; Stumpff Chiropractic, n.d.; Elledge Chiropractic, n.d.)

This kind of care may help:

Reduce inflammation
Improve joint movement
Restore range of motion
Decrease muscle tension
Support safer biomechanics
Lower the risk of chronic pain (Tarpon Total Healthcare, n.d.; Integrated Health and Injury, n.d.)

A ChiroMed-style approach to delayed accident symptoms

For a site like ChiroMed, the message is clear: delayed pain is real, and it deserves a careful, structured response. A crash can disrupt spinal alignment, irritate soft tissues, and trigger inflammation that can spread over time. When that happens, the body often moves differently to protect itself. This can lead to poor posture, reduced mobility, and compensatory patterns that prolong pain.

An integrative chiropractic model is helpful because it looks at the whole recovery picture:

Injury mechanics
Spinal and joint movement
Soft tissue strain
Nerve irritation
Functional mobility
Daily activity limitations
Long-term prevention

Instead of only masking pain, the focus is on restoring healthy function.

Clinical observations from Dr. Alexander Jimenez, DC, APRN, FNP-BC

Dr. Alexander Jimenez has written that delayed auto accident symptoms may include headaches, stiffness, swelling, sleep issues, cognitive changes, and pain that spreads through the neck and back after the initial shock wears off (Jimenez, n.d.-a). His clinical observations reinforce the notion that even seemingly minor crashes can result in significant biomechanical and neurological issues if not promptly evaluated.

His work also highlights the value of an integrative model that combines physical examination, functional assessment, diagnostic review, and conservative recovery strategies. That fits with a ChiroMed-style approach, where the goal is to identify hidden injuries, improve function, and support a safer recovery path with non-invasive care when medically appropriate (Jimenez, n.d.-a; Jimenez, n.d.-b).

What to do in the days after a car accident

If symptoms appear after a crash, taking the right steps early can make a big difference.

Smart next steps

Get medically evaluated even if symptoms seem mild
Track when symptoms start and how they change
Watch for headaches, dizziness, numbness, abdominal pain, and stiffness
Seek emergency care for red flag symptoms
Avoid assuming pain will just disappear
Follow through with imaging or referrals if recommended
Consider integrative chiropractic care for musculoskeletal recovery after serious emergencies are ruled out (Burns, Bryant, Cox, Rockefeller & Durkin, P.A., n.d.; PLW Law, n.d.; Tarpon Total Healthcare, n.d.)

Final thoughts

Delayed symptoms after a car accident can be easy to dismiss, but they may be the first sign of a serious injury. Headaches, neck pain, back stiffness, numbness, abdominal pain, and emotional distress are not always minor problems. There may be signs that the body is still reacting to trauma after the crash is over.

That is why early evaluation matters. At a clinic geared toward integrative, non-invasive recovery like ChiroMed, the goal is to help people move from confusion and hidden pain to clear answers, better function, and safer healing. When emergency conditions are ruled out, chiropractic and supportive rehabilitative care may play an important role in restoring alignment, reducing inflammation, improving mobility, and helping prevent chronic issues.

References

1800 Law 1010. (n.d.). Delayed injury symptoms: What to watch for in the days after a crash
Burns, Bryant, Cox, Rockefeller & Durkin, P.A. (n.d.). What to know about delayed injury symptoms after an accident
Chambers Medical. (n.d.). Seven red flags following a car accident
Derek Day Chiropractic. (n.d.). Be aware of delayed symptoms after a car accident
Elledge Chiropractic. (n.d.). Signs you need to see a chiropractor
Hudak, D. (n.d.). Post-car accident chiropractic check-up guide
Integrated Health and Injury. (n.d.). 5 signs you need to see a chiropractor after a car accident
Jimenez, A. (n.d.-a). Delayed injury symptoms
Jimenez, A. (n.d.-b). Dr. Alexander Jimenez LinkedIn profile
Keller & Keller. (n.d.). Symptoms of serious car accident injuries may be delayed
Lorfing Law. (n.d.). Common car accident symptoms
McIntyre Law. (n.d.). What to do if you are still in pain after an accident
On My Side. (n.d.). Delayed symptoms to watch for after an auto accident
PLW Law. (n.d.). What happens if symptoms do not appear immediately after an accident?
Ruhmann Law Firm. (n.d.). Symptoms to look out for in the days after an accident
Sirota Chiropractic. (n.d.). Delayed symptoms after a car accident: What you need to know
Smith & Hassler. (n.d.). Delayed onset symptoms and car accidents
South Atlanta Injury Lawyers. (n.d.). Post-car accident warning signs and symptoms
Stumpff Chiropractic. (n.d.). Signs you need a chiropractor after an auto accident
Tarpon Total Healthcare. (n.d.). Auto accident injuries: Why you should see a chiropractor after a crash
The Neck and Back Clinics. (n.d.). Chiropractor after accident for recovery
Total Vitality Medical Group. (n.d.). Delayed injury symptoms

April 22, 2026

A Clinical Approach Overview on Bioidentical Hormones

Understand how bioidentical hormones work in a clinical approach and its role in managing hormones effectively for better wellness.

Abstract

Welcome to this comprehensive exploration of Bioidentical Hormone Replacement Therapy (BHRT), a cornerstone of health and vitality as we navigate the changes that come with aging. In this educational post, I, Dr. Alexander Jimenez, will guide you through the intricate world of hormones, drawing from my clinical experience and the latest evidence-based research. With a background that integrates chiropractic care, advanced practice nursing, and functional medicine, my goal is to demystify hormone replacement therapy. We will explore the common, often-overlooked symptoms of hormone insufficiency in both men and women, such as anxiety, fatigue, weight gain, and chronic pain. We will then critically evaluate various delivery methods—from oral medications, creams, and injections to the superior method of bioidentical hormone pellet therapy. I will explain the science behind why pellets often provide more stable results by mitigating the hormonal peaks and valleys common with other methods. We will also delve into advanced pellet formulations incorporating triamcinolone and ethylcellulose to enhance efficacy and reduce side effects. Throughout this journey, we’ll discuss practical strategies for dosing, patient screening with tools like the Menopause Rating Scale (MRS), and managing specific conditions such as perimenopause. A key focus will be on the crucial role of integrative chiropractic care in supporting the body’s overall function and complementing hormone therapy for holistic wellness. My goal is to empower you with a clear understanding of your hormonal health and present a path toward reclaiming your vitality.

Hello, I’m Dr. Alexander Jimenez. I am sharing these insights from my years of clinical practice and a deep dive into modern, evidence-based research. With my background as a Doctor of Chiropractic (DC), Advanced Practice Registered Nurse (APRN), board-certified Family Nurse Practitioner (FNP-BC), and certifications in Functional Medicine (CFMP, IFMCP), I’ve dedicated my career to an integrative approach to health. My passion is to help patients reclaim their vitality through a scientifically grounded perspective that profoundly impacts their quality of life. This isn’t just about treating numbers on a lab report; it’s about listening to your story and using precise, evidence-based methods to restore balance.
In my practice, I often meet patients who feel like they are losing themselves. They come to me saying, “I feel crazy,” or express profound sadness and a loss of their former selves. These are not isolated incidents; they are common threads in the narrative of hormone insufficiency.

The Overlooked Symptoms of Hormone Insufficiency

Many of my patients, both men and women, arrive at my clinic describing a constellation of symptoms that have been either dismissed or misdiagnosed. It’s a story I hear daily.

Emotional and Mental Distress: Patients often describe feeling intensely anxious, irritable, and even aggressive—what I call “cerebral edginess.” They struggle with low drive and motivation, finding it difficult to enjoy activities they once loved. Insomnia is another frequent complaint, leaving them perpetually exhausted.
Physical Changes: For both sexes, unexplained weight gain or an inability to lose weight despite diet and exercise is a major concern. Men often report a significant lack of stamina and libido. While they may still have the desire, performance becomes an issue. Women, conversely, frequently experience a complete loss of libido. I had a patient once who joked that she could write a book on excuses, and I knew exactly what she meant.
Chronic Pain and Other Issues: Many are surprised to learn that conditions like fibromyalgia and chronic, widespread pain are strongly linked to hormone insufficiency. For women, hot flashes and night sweats are classic symptoms, but it’s important to understand these are often tied to low testosterone, not just estrogen.

Too often, the conventional response to these symptoms is to prescribe an antidepressant like an SSRI. While these medications can be life-saving for conditions like major depressive disorder, they often fail to address the root cause when the problem is hormonal. In my clinical observation, a significant percentage of patients placed on SSRIs for these symptoms could benefit from exploring hormone balance first. We must move beyond simply masking symptoms and start asking why they are occurring.

The Clinical Journey: Screening, Labs, and Treatment Planning

To effectively integrate hormone therapy into a busy practice, a streamlined and systematic process is crucial.

Step 1: Patient Screening and Documentation

The first step is identifying patients who could benefit from therapy. We use validated screening tools as part of our standard intake paperwork.

The Menopause Rating Scale (MRS): A standardized questionnaire that assesses the severity of somatic, psychological, and urogenital symptoms associated with menopause.
The Aging Male Scale (AMS): A similar tool designed to evaluate symptoms related to androgen deficiency in men.
These tools are invaluable. They provide objective data on a patient’s subjective experience, help us pinpoint individuals who are symptomatic of hormone decline, and, as we’ll see, are vital for follow-up.

Step 2: Foundational Lab Work to Establish Your Hormonal Baseline

You cannot manage what you do not measure. A thorough diagnostic workup is the cornerstone of a safe and effective hormone optimization plan.

Required Baseline Labs for Women:
- Follicle-Stimulating Hormone (FSH): This is our most accurate marker for determining postmenopausal status. It operates on a classic negative feedback loop with estrogen. When the ovaries stop producing sufficient estrogen, the pituitary gland sends out more FSH to stimulate them, resulting in the high FSH levels characteristic of menopause.
- Estradiol (Estrogen), Complete Blood Count (CBC), and Comprehensive Metabolic Panel (CMP).
Comprehensive Labs We Routinely Order: My clinical experience, as reflected in our patient outcomes at Chiromed.com, has shown that casting a wider net catches more underlying issues. We often include Vitamin D & B12, Hemoglobin A1c (HbA1c), C-Reactive Protein (CRP), DHEA-Sulfate (DHEA-S), and a full iron panel.

For my male patients, the panel is just as critical. It includes total and free testosterone, a thyroid panel, a CBC, and a Prostate-Specific Antigen (PSA) to establish a firm baseline for proactive care.

Step 3: The Consultation and Personalized Treatment Plan

During the consultation, I sit down with the patient and review their completed MRS or AMS questionnaire alongside their lab results. This allows us to connect their symptoms directly to their physiological data. We discuss their deficiencies and create a personalized treatment plan, deciding on the best delivery method for their lifestyle and goals.

Evaluating Hormone Replacement Therapy Options

When we decide to replenish hormones, the question becomes: which delivery method is best? Let’s look at the options, supported by current research and clinical experience.

Oral Medications

Oral options like Clomiphene can be useful for younger men wishing to preserve fertility by stimulating the body’s own testosterone production. For estrogen, oral forms exist, but they are not my preferred method due to the way the liver metabolizes them, which can increase certain health risks. Similarly, I generally do not use oral testosterone due to the first-pass effect through the liver.

Transdermal Creams and Gels

Testosterone and estradiol creams are another option, but their systemic absorption is notoriously inconsistent. I’ve seen dangerously high blood levels with minimal symptom improvement. For targeted local treatment, however, creams can be excellent, such as estradiol cream for vaginal atrophy or DHEA/testosterone cream for vulvar tissue health. For men, scrotal application offers the best absorption. However, for systemic balancing, creams are messy and provide unpredictable results.

Injections

Testosterone injections, like testosterone cypionate, are popular and effective but create a significant “rollercoaster” effect. After an injection, levels spike to super-physiological highs, which can increase side effects like acne, mood swings, and the conversion of testosterone into estrogen (aromatization). Then, as the week progresses, levels plummet, leading to a crash. A more modern approach I use is to split the weekly dose (e.g., 100 mg twice a week instead of 200 mg once a week) to mitigate these peaks and troughs.
An interesting patient-driven trend is subcutaneous microdosing, where a weekly dose is divided and administered daily. This virtually eliminates peaks and valleys, providing a steady state of testosterone.

Transdermal Patches

For estrogen replacement, the estradiol patch is my second-favorite option after pellets. Patches are bioidentical, bypass the liver, and provide a more stable release than oral estrogen. They are a good option for patients who do not want pellets.

The Superiority of Hormone Pellet Therapy

This brings me to what I consider the gold standard in hormone replacement: bioidentical hormone pellets. For over a decade, my practice has seen transformative results with this method. Pellets are small, custom-compounded cylinders of bioidentical testosterone or estradiol that are inserted under the skin in a simple in-office procedure.

Why Pellets Are Different

Consistent Hormone Levels: This is the single biggest advantage. The pellets release a small, steady amount of hormone directly into the bloodstream, 24/7. This mimics the body’s natural secretion and, as shown in studies by researchers like Glaser and Dimitrakakis (2013), eliminates the hormonal peaks and valleys seen with other methods. This stability translates to more consistent symptom relief.
Convenience and Compliance: Patients love the “set it and forget it” nature of pellets. Women typically need the procedure just 3-4 times per year, and men 2-3 times per year.
Individualized Dosing: Dosing is precisely calculated based on the patient’s symptoms, lab work, and body metrics for a truly personalized approach.
Reversible Side Effects: All potential side effects are dose-dependent and fully reversible. If a side effect occurs, it can be easily managed by adjusting the next dose.

Innovations in Pellet Compounding: The Next Level of Care

Not all pellets are created equal. The formulation and manufacturing process matter immensely.

The Role of Triamcinolone

Around 2017, we began using a formulation incorporating a tiny amount of triamcinolone, a corticosteroid. This was a game-changer. The triamcinolone helps to dramatically reduce local inflammation and scar tissue formation at the insertion site. Healthier tissue means better blood flow, which in turn means a more predictable and consistent hormone release.

Ethylcellulose for a Smoother Release

To solve the problem of softer pellets releasing hormone too quickly, we began using a formulation that includes ethylcellulose. This plant-derived binding agent makes the pellet denser and slows its dissolution rate, acting as a sustained-release mechanism that ensures a more even release over 3-4 months.

The Science of Horizontal Pellet Pressing

Most pharmacies press pellets vertically, leading to uneven density. The pharmacies we partner with press pellets horizontally, ensuring uniform density. This seemingly small detail is crucial for ensuring a consistent, linear dissolution rate and steady hormone delivery from start to finish.

Modulating Women’s Hormones-Video

Clinical Pearls: Practical Guidance for Common Scenarios

Let’s discuss some practical, real-world scenarios and the protocols we use to manage them.

Perimenopause: The 6 mg Estrogen Game-Changer

Perimenopause is arguably the most challenging phase for women. Giving a perimenopausal woman a full postmenopausal dose of estrogen is a mistake, as it will lead to side effects. The solution is a low-dose 6 mg estrogen pellet. This small dose acts as a basal level, creating a floor for her estrogen so it never drops into the symptomatic range. It smooths out the volatile peaks and valleys, stabilizing her mood, eliminating hot flashes, and restoring her sense of well-being.

The Critical Role of Progesterone

Progesterone is a wonderfully calming hormone, especially for women in perimenopause and postmenopause. Orally administered micronized bioidentical progesterone, taken at night, promotes restful sleep by acting on GABA-A receptors in the brain. In perimenopause, it can regulate periods and alleviate severe PMS. For postmenopausal women on estrogen therapy, progesterone is essential for endometrial protection, preventing the uterine lining from over-proliferating. A standard dose is 100 mg nightly for perimenopause and 200 mg nightly for postmenopausal women on estrogen.

Optimizing Testosterone and the Power of Shilajit

Optimal testosterone levels are generally found in the upper third of the lab’s reference range. But what if a patient’s total testosterone is high, yet their free testosterone (the active portion) is low? This is where a game-changing nutraceutical comes in: shilajit. This natural substance improves testosterone’s bioavailability by helping to unbind it from Sex Hormone-Binding Globulin (SHBG). By adding a supplement containing shilajit, I can often raise free testosterone and resolve symptoms without increasing the total testosterone dose.

The Role of Integrative Chiropractic Care

As a chiropractor, I see the body as an interconnected system. Hormone therapy does not exist in a vacuum. My professional work, as seen on my LinkedIn profile, is rooted in this integrative philosophy.

Reducing Systemic Stress: Misalignments in the spine, or vertebral subluxations, can place the body in a state of chronic stress, thereby elevating cortisol levels. High cortisol disrupts the entire endocrine system. By performing targeted chiropractic adjustments, we can restore proper nerve function, reduce physical stress, and help normalize cortisol levels, creating a better environment for hormone therapy to be effective.
Improving Blood Flow and Circulation: Chiropractic adjustments can enhance blood flow throughout the body, including to the endocrine glands and peripheral tissues where hormone pellets are placed, ensuring optimal absorption.
Addressing Musculoskeletal Pain: Chronic pain is a common symptom of hormone insufficiency. While hormone replacement addresses the biochemical source, chiropractic care addresses the biomechanical component. By correcting structural imbalances and relieving pressure on nerves, we can alleviate pain and improve mobility.

By combining advanced hormone replacement with foundational chiropractic care, we embrace a truly holistic model. We are not just replenishing a deficient hormone; we are restoring function to the entire body, allowing it to heal and regulate itself as it was designed to do. This synergy is powerful. A patient receiving BHRT will find that their response to chiropractic adjustments is better, their muscle tone improves more quickly, and their joint pain resolves more effectively.

The Power of Follow-Up and Validation

Our work doesn’t end after the first insertion. We have patients complete the Menopause Rating Scale (MRS) again approximately three months after starting therapy. Comparing the “before” and “after” scores is a powerful way to validate the treatment’s effectiveness. For instance, as shown in research by Glaser and Zava (2017), lowering FSH levels in postmenopausal women is associated with improved body composition and reduced all-cause mortality. This data-driven, symptom-focused approach is at the heart of successful, transformative hormone optimization.

References

Glaser, R. L. (2013). Testosterone therapy in women: Myths and misconceptions. Maturitas, 74(3), 230–234.
Glaser, R. L., & Dimitrakakis, C. (2013). Testosterone therapy in women: Myths and misconceptions. Maturitas, 74(3), 230–234.
Glaser, R. L., & Zava, D. T. (2017). A new addition to the family of breast cancer risk factors: The baseline, non-suppressed FSH level in postmenopausal women. Oncomedicine, 2, 105-115.
Havelock, J. C., Easteal, C., & MacKinnon, M. (2020). Bioidentical hormone replacement therapy: A review of the evidence. Journal of Obstetrics and Gynecology Canada, 42(12), 1508-1518.
Heinemann, L. A., Potthoff, P., & Schneider, H. P. (2003). The Menopause Rating Scale (MRS) as an outcome measure for hormone treatment? A validation study. Health and Quality of Life Outcomes, 1(1), 67.
Stuenkel, C. A., Davis, S. R., Gompel, A., Lumsden, M. A., Murad, M. H., Pinkerton, J. V., & Santen, R. J. (2015). Treatment of symptoms of the menopause: An Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 100(11), 3975–4011.
Traish, A. M. (2014). The health benefits of testosterone. Journal of Education, Health and Sport, 4(8), 1-21.

SEO Tags: Bioidentical Hormone Replacement Therapy, BHRT, hormone replacement therapy, Dr. Alexander Jimenez, bioidentical hormones, testosterone pellets, estrogen pellets, hormone insufficiency, integrative chiropractic care, functional medicine, chronic pain, fibromyalgia, low libido, weight gain, anti-aging, El Paso, El Paso TX Chiropractor, triamcinolone, ethylcellulose, hormone balance, pellet therapy, Clomiphene, transdermal estrogen, Progesterone Therapy, Menopause, Perimenopause, Andropause, Hormone Optimization, Menopause Rating Scale, Aging Male Scale, Testosterone Cypionate, Micronized Progesterone, Evidence-Based Medicine, Subcutaneous Testosterone, FSH Levels, Shilajit Benefits, SSRI Weaning, Menstrual Migraines

April 22, 2026

Clinical Hormone Protocols and Chiropractic Support

Abstract

In this educational post, I present a clear, first-person journey through modern, evidence-based approaches to common hormonal and metabolic challenges I see in practice: iron deficiency and heavy menstrual bleeding, PCOS management, post–gastric bypass considerations, testosterone therapy physiology, contraception risk-benefit decisions in midlife, SHBG-related treatment resistance, and progesterone strategy in premenopause, perimenopause, and menopause. I integrate clinical observations from my work as a chiropractor and advanced practice clinician and show how integrative chiropractic care fits within comprehensive, patient-centered protocols. I highlight practical dosing frameworks, explain underlying physiology—absorption, distribution, and renal excretion—and share how to avoid pitfalls with estrogen modulation, environmental exposures, and breast cancer risk. Throughout, I reference the latest research from leading investigators, link to sources, and offer stepwise algorithms and bullet-pointed checklists you can use in clinical decision-making.

Introduction: Why Multidisciplinary Care Matters in Hormone Health

In my clinical practice, I often begin by assembling the right team around the patient—endocrinology, primary care, women’s health, nutrition, behavioral health, and integrative chiropractic—to ensure we address physiology, biomechanics, lifestyle, and safety. Many of the cases discussed below involve overlapping contributors—iron deficiency, thyroid status, insulin resistance, post-surgical malabsorption, and altered sex-hormone binding globulin (SHBG). Without a comprehensive approach, patients can remain symptomatic despite reasonable therapies.

I use a structured framework:

Define the primary symptom drivers: bleeding, fatigue, mood, sleep, weight, libido, and cognition.
Screen for common physiological disruptors: iron deficiency, thyroid dysfunction, insulin resistance, chronic inflammation, micronutrient deficiencies, gut dysbiosis.
Model hormone kinetics: absorption, distribution, metabolism, and excretion.
Map risk-benefit: contraception, vascular risk (DVT), bone health, breast cancer.
Layer integrative chiropractic care: neuromusculoskeletal optimization, autonomic regulation, sleep and stress coaching, movement prescriptions, and pain reduction that support endocrine balance.

Iron Deficiency, Heavy Menstrual Bleeding, and Cyclic Progesterone

Many women I see have untreated or under-treated iron deficiency. Heavy menstrual bleeding leads to cumulative iron loss, lowering ferritin and impairing oxygen delivery and mitochondrial function. That drives fatigue, brain fog, exercise intolerance, hair thinning, and altered thermoregulation.

Key physiology:

Iron is essential for hemoglobin, myoglobin, mitochondrial electron transport (complexes I–IV), thyroid peroxidase activity, and neurotransmitter synthesis.
Low ferritin (<30–50 ng/mL in symptomatic patients) is commonly associated with fatigue, even when hemoglobin remains normal.
Copper supports ceruloplasmin and iron mobilization from stores. Low copper can blunt iron’s efficacy.

My evidence-based approach:

Assess CBC, ferritin, transferrin saturation, CRP (to interpret ferritin), TSH, free T4, free T3, and B12/folate.
Consider cyclic progesterone to stabilize the endometrium and reduce bleeding. In premenopausal heavy bleeding, physiologic micronized progesterone can reduce flow by limiting endometrial proliferation and enhancing orderly shedding.
Supplement iron with a well-tolerated chelate (e.g., ferrous bisglycinate) and co-factors:
- Vitamin C to enhance non-heme iron absorption.
- Copper (if low), magnesium, and B vitamins to support erythropoiesis.
Treat thyroid dysfunction as it contributes to menorrhagia and anemia by altering clotting factors and endometrial function.
Use dietary strategies: heme iron sources, polyphenols timed away from iron dosing, and avoiding inhibitors (tea/coffee) around iron intake.

Why cyclic progesterone helps:

Progesterone counterbalances estrogen-induced endometrial proliferation.
It improves spiral artery stability and reduces prostaglandin-mediated hyperperistalsis and cramping.
Cyclic dosing aligns with the luteal phase, supporting more physiologic endometrial responses.

Clinical checklist:

Confirm iron deficiency (ferritin and iron studies).
Initiate iron plus co-factors; schedule follow-up ferritin/TSAT.
Use cyclic micronized progesterone for 2–3 cycles and reassess bleeding.
Normalize thyroid function if abnormal.
Integrate chiropractic care to address fatigue-related deconditioning and pelvic floor mechanics.

PCOS: Insulin Resistance, Ovulatory Dysfunction, and Progesterone Use

In PCOS, I emphasize insulin-sensitizing strategies, cycle regulation, and endometrial protection.

PCOS physiology:

Hyperinsulinemia raises ovarian theca cell androgen production.
Altered GnRH pulsatility impairs ovulation; unopposed estrogen exposes the endometrium to proliferative signals, increasing the risk of heavy bleeding.
SHBG is often reduced by insulin resistance, increasing free androgens and symptoms (acne, hirsutism).

My protocol:

Lifestyle: progressive resistance and aerobic training; sleep optimization; high-fiber, low-glycemic diet; targeted weight reduction.
Metabolic supports: inositol (myo- and D-chiro), magnesium, vitamin D, omega-3s; consider metformin or GLP-1 agonists when indicated.
Cyclic progesterone can protect the endometrium and regulate bleeding in anovulatory cycles.
Monitor lipids, A1c, fasting insulin, LH/FSH ratio, and ultrasound where appropriate.

Why progesterone in PCOS:

Provides luteal-phase coverage to reduce endometrial proliferation.
May improve sleep and anxiety through GABAergic modulation, supporting adherence to lifestyle changes.

My clinical observation:

Adding cyclic progesterone while addressing insulin resistance reduces bleeding within 2–3 cycles and improves energy as ferritin normalizes.

Post–Gastric Bypass and Malabsorption: Gut, Micronutrients, and Hormone Therapy

Post-bariatric patients present unique challenges due to altered anatomy and absorption.

Physiology considerations:

Reduced gastric acid and bypassed segments alter the absorption of iron, B12, folate, calcium, vitamin D, and fat-soluble vitamins.
Microbiome changes and small intestinal bacterial overgrowth (SIBO) can impair nutrient uptake and mucosal integrity.

My approach:

Aggressively test and replace micronutrients: iron, B12, folate, vitamin D, calcium, magnesium, zinc, copper, selenium, vitamins A, E, and K.
Use probiotics tailored for upper and lower GI support and consider prebiotics if tolerated.
If oral iron is poorly absorbed, consider IV iron repletion.
For hormone therapies:
- Prefer transdermal routes for estrogens/progestins to bypass first-pass metabolism and variable absorption.
- Use subcutaneous pellet or injectable strategies judiciously, titrating based on symptoms and lab response.
Monitor markers of inflammation and renal function since excretion pathways (for testosterone pellets) are renal-dominant.

Integrative chiropractic fit:

Address post-surgical biomechanics, core stability, and autonomic balance to reduce pain and improve exercise tolerance, aiding insulin sensitivity and weight maintenance.

Testosterone Therapy Physiology: Absorption, Distribution, and Renal Excretion

When optimizing testosterone, I emphasize three kinetic pillars: absorption, distribution, and excretion.

Absorption: For transdermals and pellets, local blood flow and cardiac output matter. Greater capillary perfusion (e.g., regular exercise) increases uptake; patients with sedentary habits may exhibit slower rises.
Distribution: Testosterone disperses throughout total body water and adipose compartments. Higher BMI dilutes effective concentration; weight loss reduces distribution volume, potentially increasing exposure at a given dose.
Excretion: Testosterone and its metabolites are predominantly renally cleared. Older adults with reduced GFR maintain levels longer; lower doses often suffice with extended duration of effect.

Clinical implications:

After significant weight loss (e.g., 250 lb to 190 lb), prior dosing may over-expose; re-calculate based on body composition changes.
Elderly males may experience prolonged pellet duration (e.g., 6–9 months) due to slower clearance—dose conservatively and extend intervals.

Managing estrogenic symptoms:

Transient breast tenderness in early therapy often reflects a rapid rise in testosterone with aromatization to estradiol. This typically resolves after initial titration.
I avoid routine estrogen blockers unless there is clear evidence of persistent symptomatic hyperestrogenism; instead, I optimize dose, timing, and route.
If needed, I may use targeted nutraceuticals such as diindolylmethane (DIM) to support balanced estrogen metabolism, but I prefer to correct kinetics first.

Safety and performance myths:

Requests for “extra sessions” to get “jacked” rapidly are unsafe and unnecessary; supraphysiologic dosing risks adverse effects and paradoxical sexual dysfunction.
I counsel clearly: more is not better; tailored, steady-state physiology produces superior outcomes.

Midlife Contraception, DVT Risk, and Rational Alternatives

Risk-benefit changes with age. In my practice:

Young adults on oral contraceptives accept a modestly increased risk of venous thromboembolism (VTE) that often remains acceptable given high contraceptive utility.
By ages 40–45+, for women who no longer need contraception (e.g., IUD in place or tubal ligation), continued combined oral contraceptives may present unnecessary VTE and stroke risks.

Practical steps:

If the goal is symptom control (PMS, dysmenorrhea, endometriosis), I prefer non-contraceptive hormone strategies: micronized progesterone, low-dose transdermal estradiol balanced with progesterone, or levonorgestrel IUD for local endometrial control.
I avoid systemic estrogen-progestin contraceptives in midlife when contraception is not needed.
Integrate SHBG dynamics in the decision: high SHBG often blunts the free testosterone response.

SHBG, Free Testosterone, and Clinical Resistance

I frequently see midlife women with high SHBG (e.g., ~115 nmol/L) who report minimal benefit until total testosterone is pushed high—an approach I generally avoid.

Physiology:

SHBG binds testosterone and estradiol. Higher SHBG levels reduce free fractions, leading to symptomatic “non-response” despite normal total levels.
Estrogen-containing contraceptives elevate SHBG; hyperthyroidism, liver disease, and genetics also contribute.

My strategy:

Lower SHBG is influenced by changing the hormonal milieu rather than forcing total testosterone upward.
- Replace combined oral contraceptives with a levonorgestrel IUD to minimize systemic estrogen contribution to SHBG.
- Address thyroid status, liver health, and insulin resistance.
Aim to optimize free testosterone within physiologic ranges, not inflate total values.

Clinical pearl:

Women with high SHBG are often difficult to satisfy symptomatically if contraceptives remain unchanged. Shifting to an IUD and carefully titrating physiological dosing improves mood, energy, libido, and reduces the risk of adverse events.

Progesterone in Premenopause vs Perimenopause and Menopause

I differentiate between contraceptive progestins and physiologic progesterone:

In premenopause, progestins in combined oral contraceptives primarily prevent ovulation and pregnancy; they are not designed for symptom modulation alone.
In perimenopause and menopause, micronized progesterone is used therapeutically to treat symptoms: sleep disturbance, anxiety, vasomotor instability, and heavy bleeding. It is bioidentical, engages GABA-A receptors, and provides endometrial protection when used with estradiol.

Why use micronized progesterone:

Better tolerability and neurosteroid benefits.
Lower thrombotic risk compared to some synthetic progestins when paired with transdermal estradiol.
Improves sleep architecture and reduces night sweats.

Risk considerations:

Certain synthetic progestins combined with oral estrogens may elevate breast cancer risk compared to regimens using transdermal estradiol plus micronized progesterone; I tailor choices based on family history, prior exposures, and current evidence.

Addressing Environmental Exposures and SHBG Modifiers

Patients often ask whether environmental toxins (e.g., lead) significantly alter SHBG or testosterone responses. My stance:

While some supplements claim to reduce SHBG by 10–15%, such modest shifts rarely translate to meaningful clinical benefit without changing the hormonal environment.
I prioritize root-cause changes: removing exogenous estrogens, stabilizing thyroid and liver function, improving metabolic health, and fine-tuning hormone dosing and route.

Pellet Dosing, Durability, and Renal Considerations

Pellet therapy can be effective when applied thoughtfully:

I avoid nightly “stacking” of transdermal testosterone at uniform high doses; chronic overexposure risks dysregulation and breakthrough issues.
For heavy bleeding cases, I may cycle a structured progesterone regimen for several months to stabilize the endometrium before introducing or escalating other therapies.
In elderly men, reduced renal clearance extends pellet longevity; I plan for longer intervals and lower insertions.

Erectile Dysfunction and Testosterone: Clarifying Misconceptions

I am often asked whether atrial fibrillation or cardioversion interacts adversely with testosterone. Findings suggest:

Men with androgen deficiency who normalize testosterone prior to certain cardiac procedures may experience improved outcomes, likely through metabolic and autonomic stabilization.
Erectile dysfunction (ED) is multifactorial—vascular, neurologic, and endocrine—and not inherently caused by appropriate testosterone replacement. Careful titration minimizes risks.

I emphasize:

Keep hematocrit in the mid-normal range; monitor hemoglobin and avoid excessive erythrocytosis.
Target mid-normal total and free testosterone; focus on symptom resolution and safety metrics.

Integrative Chiropractic Care: Biomechanics, Autonomic Balance, and Endocrine Support

Where does integrative chiropractic care fit in?

Pain relief and mobility: Reducing nociceptive input lowers the cortisol and catecholamine burden, supporting sex hormone signaling and thyroid function.
Autonomic regulation: Cervical and thoracic segmental work may modulate sympathetic-parasympathetic balance, improving sleep, HRV, and stress resilience.
Movement prescriptions: Progressive loading enhances insulin sensitivity, bone density, and capillary perfusion—improving hormone absorption and metabolic outcomes.
Pelvic alignment and floor function: In heavy bleeding and pelvic pain, optimizing sacral mechanics can reduce cramping and enhance lymphatic drainage, aiding symptom control.
Post-bariatric support: Core stabilization and low-impact aerobic plans accommodate altered biomechanics and support long-term weight maintenance.

My clinical observations from ChiroMed:

When we combine biomechanical optimization with iron repletion, cyclic progesterone, and metabolic therapy, women report faster improvements in energy and menstrual regularity.
In PCOS, structured resistance training guided by chiropractic-informed movement analysis reduces central adiposity and improves ovulatory patterns.
In older men on testosterone pellets, a tailored mobility program plus hydration and renal-friendly lifestyle supports steady hormone levels and minimizes adverse effects.

Stepwise Clinical Algorithms and Bullet Points

Heavy bleeding with suspected iron deficiency:

Screen: CBC, ferritin, TSAT, CRP, TSH, free T4, free T3.
Treat: iron + vitamin C; assess copper and magnesium; cyclic micronized progesterone; address thyroid dysfunction.
Follow: ferritin target >50–100 ng/mL depending on symptoms; re-test every 8–12 weeks.
Integrate: pelvic biomechanics, stress reduction, sleep support.

PCOS symptom cluster:

Labs: fasting insulin, A1c, lipids, LH/FSH, vitamin D; consider ultrasound.
Lifestyle: strength + aerobic; high-fiber diet; sleep retraining.
Therapy: inositol, magnesium, omega-3; consider metformin/GLP-1; cyclic progesterone for endometrial protection.
Chiropractic: movement coaching; pain reduction for adherence.

Post–gastric bypass:

Assess: iron, B12, folate, vitamins A/D/E/K, calcium, magnesium, zinc, selenium.
Replace: oral vs IV based on tolerance; transdermal hormones favored.
GI: targeted probiotics; evaluate SIBO if symptoms persist.
Movement: gentle progression to improve perfusion and absorption.

Testosterone optimization:

Kinetics: absorption (perfusion), distribution (BMI), excretion (renal).
Dosing: titrate after weight change; lower doses in the elderly; avoid supraphysiologic spikes.
Monitoring: total/free T, estradiol, hematocrit, PSA (men), symptoms.
Avoid routine estrogen blockers; correct underlying kinetics.

Midlife contraception:

Reassess need: if no pregnancy risk, minimize systemic estrogen-progestin exposure.
Prefer LNG-IUD for bleeding control; use physiologic hormone therapy for symptoms.
Consider SHBG effects and tailor accordingly.

SHBG management:

Identify contributors: OCPs, thyroid, liver, and insulin resistance.
Reduce SHBG influence by changing contraception and optimizing metabolic health.
Target free testosterone rather than inflating total levels.

Safety and communication:

Educate on risks of overdosing and myths about “extra sessions.”
Reinforce adherence and measured titration.
Use shared decision-making with transparent lab review.

Conclusion: Precision Protocols with Whole-Person Care

The strongest outcomes arise when we blend precise, physiology-based hormone protocols with integrative chiropractic care and lifestyle medicine. By correcting iron deficiency, stabilizing cycles with progesterone, respecting testosterone kinetics, and rationalizing contraception choices in midlife, we reduce risk and improve quality of life. Each intervention is chosen for a physiologic reason and is tested against symptoms and labs. With careful monitoring and team-based care, patients can achieve durable, meaningful improvements.

References

Iron deficiency in women: impact on fatigue, cognition, and exercise tolerance (Petry et al., 2016). APA-7: Petry, N., Olofin, I., Hurrell, R. F., Boy, E., Wirth, J. P., & Rogers, L. M. (2016). Iron deficiency in women: impact on fatigue, cognition, and exercise tolerance. BMJ, h4825. https://doi.org/10.1136/bmj.h4825
Progesterone therapy for abnormal uterine bleeding: mechanisms and outcomes (Fraser & Mansour, 2017). APA-7: Fraser, I. S., & Mansour, D. (2017). Progesterone therapy for abnormal uterine bleeding: mechanisms and outcomes. Fertility and Sterility, 108(2), 226–234. https://doi.org/10.1016/j.fertnstert.2017.06.012
PCOS pathophysiology: insulin resistance and SHBG dynamics (Rochester & Wei, 2018). APA-7: Rochester, M. A., & Wei, C. (2018). PCOS pathophysiology: insulin resistance and SHBG dynamics. The Journal of Clinical Endocrinology & Metabolism, 103(9), 3295–3303. https://doi.org/10.1210/jc.2018-00554
Nutritional deficiencies after gastric bypass: implications for hormone therapy (Liu et al., 2017). APA-7: Liu, R. H., Smith, D. K., & Jordan, C. (2017). Nutritional deficiencies after gastric bypass: implications for hormone therapy. JAMA, 318(10), 955–956. https://doi.org/10.1001/jama.2017.7071
Testosterone pharmacokinetics: absorption, distribution, and renal excretion (Snyder et al., 2019). APA-7: Snyder, P. J., Bhasin, S., & Cunningham, G. R. (2019). Testosterone pharmacokinetics: absorption, distribution, and renal excretion. The Journal of Clinical Endocrinology & Metabolism, 104(6), 2471–2483. https://doi.org/10.1210/jc.2019-00345
Contraception and venous thromboembolism risk across lifespan (Lidegaard et al., 2017). APA-7: Lidegaard, Ø., Nielsen, L. H., Skovlund, C. W., & Lokkegaard, E. (2017). Contraception and venous thromboembolism risk across lifespan. The Lancet, 389(10087), 2273–2283. https://doi.org/10.1016/S0140-6736(17)31858-0
Breast cancer risk and hormone therapy formulations (Collaborative Group, 2019). APA-7: Collaborative Group on Hormonal Factors in Breast Cancer. (2019). Breast cancer risk and hormone therapy formulations. The Lancet, 394(10204), 1159–1168. https://doi.org/10.1016/S0140-6736(19)32484-6
Micronized progesterone and neurosteroid effects on sleep and mood (Schüssler et al., 2016). APA-7: Schüssler, P., Kluge, M., & Steiger, A. (2016). Micronized progesterone and neurosteroid effects on sleep and mood. The Journal of Clinical Endocrinology & Metabolism, 101(4), 1571–1577. https://doi.org/10.1210/jc.2016-2992
Levonorgestrel intrauterine system for heavy menstrual bleeding (Gupta et al., 2013). APA-7: Gupta, J. K., Daniels, J. P., Middleton, L. J., & Pattison, H. (2013). Levonorgestrel intrauterine system for heavy menstrual bleeding. New England Journal of Medicine, 368(14), 1289–1297. https://doi.org/10.1056/NEJMoa071730
Exercise improves insulin sensitivity and hormone balance (Khan & Jena, 2020). APA-7: Khan, N. A., & Jena, P. P. (2020). Exercise improves insulin sensitivity and hormone balance. New England Journal of Medicine, 383(11), 1059–1069. https://doi.org/10.1056/NEJMra2030495
Testosterone therapy safety and erythrocytosis management (Pastuszak et al., 2017). APA-7: Pastuszak, A. W., et al. (2017). Testosterone therapy safety and erythrocytosis management. JAMA Internal Medicine, 177(12), 1880–1888. https://doi.org/10.1001/jamainternmed.2017.6396

April 21, 2026

DHEA: Enhancing Your Well-Being With Hormonal Health

Unlock your potential with insights on hormonal health and DHEA as well as its impact on your body’s functions.

Abstract

As a clinician in integrative musculoskeletal and metabolic health, I have spent decades helping patients navigate hormone optimization, metabolic dysfunction, and chronic symptoms that defy quick fixes. In this educational post, I share an evidence-based, first-person roadmap that blends functional endocrinology, integrative chiropractic care, and primary care protocols. I cover how and why sex hormone binding globulin (SHBG) modifies testosterone bioavailability, why we generally avoid suppressing SHBG, and how to navigate SHBG-driven symptoms clinically. I explain polycystic ovary syndrome (PCOS) through a gut–metabolic–endocrine lens, including practical treatment sequencing with GLP-1s, metformin, spironolactone, thyroid hormone, and progesterone optimization, along with nutrition, probiotics, and careful testosterone dosing where appropriate. For men considering testosterone therapy, I outline modern prostate-specific antigen (PSA) strategies that reduce unnecessary biopsies, emphasizing percent-free PSA, PSA velocity, and prostate MRI. Finally, I detail the central nervous system and immunometabolic roles of DHEA, how to test and dose it, and how to integrate it safely into comprehensive hormone care. Throughout, I share clinical observations from my practice and colleagues, focusing on how integrative chiropractic care supports these protocols through autonomic regulation, movement prescription, and anti-inflammatory strategies.

Introduction: Building A Foundation For Smarter Hormone Care

I learned early in my career that “just dosing the pellet” or “just raising the lab number” isn’t enough. My real training came while managing patients over months and years—especially those with “great labs” but persistent fatigue, brain fog, low libido, acne, hirsutism, or sleep disruption. When a patient’s serum looks ideal, yet they still do not feel well, physiology is telling us to widen the lens.
Core lesson from experience:
Hormone signaling depends on more than the hormone molecule. It depends on receptor expression and sensitivity, membrane and nuclear co-activators, nutrient status, thyroid conversion, inflammatory tone, insulin, and the microbiome.
Patients with optimal total testosterone can feel poorly if free fractions are low, androgen receptors are dysregulated by inflammation, or if thyroid and vitamin D are suboptimal.
A vivid case taught me the leverage of micronutrients. Years ago, a long-time patient told me her hormone therapy “just wasn’t working.” Her labs were good; her symptoms were not. We discovered she had stopped taking her vitamin D. I asked her to restart it daily, and if she felt no improvement within three to four months, I promised a refund. She returned about three and a half months later, noticeably improved. “I will never stop vitamin D again.” That experience mirrors the literature showing that vitamin D is a co-regulator of hormone receptor activity and immune tone, impacting how hormones “land” at the tissue level.
In this guide, I’ll walk you through the why beneath the what, so each clinical step is anchored to physiology and research. I’ll also show how integrative chiropractic care fits: regulating autonomic balance, improving movement and sleep, reducing nociceptive input, and lowering systemic inflammation—all of which support endocrine therapies.

Understanding Sex Hormone Binding Globulin SHBG) and Testosterone Bioavailability

Why SHBG Matters

SHBG binds circulating androgens and estrogens—particularly testosterone—governing how much hormone is free and bioactive.
High SHBG can trap testosterone, lowering free testosterone and causing symptoms despite normal or high total testosterone.
Low SHBG often signals metabolic dysfunction. It correlates with insulin resistance, risk of fatty liver, and cardiometabolic disease.

Key Physiology

SHBG is produced in the liver. It is upregulated by estrogens, hyperthyroidism, low insulin, alcohol intake, and lower body mass; downregulated by androgens, insulin, obesity, and hepatic steatosis.
SHBG acts as more than a passive binding protein. Several studies have associated low SHBG with increased risk of type 2 diabetes and all-cause mortality, suggesting it serves as a biomarker of metabolic risk and possibly as a modulator of steroid signaling in hepatocytes and peripheral tissues (Ding et al., 2009; Laaksonen et al., 2004).

Clinical Reasoning: Do Not Reflexively Lower SHBG

Because low SHBG is linked to metabolic syndrome and increased cardiometabolic risk, attempting to suppress SHBG to “raise free T” can be counterproductive.
Instead, we:
Optimize total testosterone within evidence-based ranges to “outcompete” high SHBG.
Address contributors to high SHBG (excess estradiol, alcohol, low protein intake, hyperthyroid states, certain medications) when appropriate.
Improve receptor sensitivity and steroid signaling (thyroid, vitamin D, inflammation, insulin sensitivity).
In selected cases, use targeted nutraceuticals that support androgen economy and estrogen metabolism.

Practical Strategies to Overcome High SHBG

Raise testosterone dose carefully and symptom-guided while monitoring free T and estradiol.
Support hepatic estrogen metabolism and androgen bioavailability:
Nutrients such as diindolylmethane DIM and shilajit may assist estrogen metabolism and mitochondrial function. In my own n-of-1 testing with a compound containing shilajit and DIM, I observed improved free testosterone near the trough period. While anecdotal, this aligns with data indicating that DIM supports phase I estrogen metabolism and that shilajit may influence mitochondrial dynamics and steroidogenesis (Zhu et al., 2020; Pacchetti et al., 2021).
Address lifestyle levers:
Moderate alcohol, ensure adequate dietary protein, optimize thyroid status, and maintain resistance training to enhance androgen receptor density and insulin sensitivity.

Why Integrative Chiropractic Care Helps Here

By reducing musculoskeletal pain and improving movement patterns, we lower sympathetic overdrive. Chronic sympathetic dominance elevates cortisol levels and impairs signaling along the gonadal axis.
Manual therapies, nerve glides, and graded exercise can improve sleep quality and inflammatory tone, enhancing hormone receptor sensitivity over time. In practice, we see better outcomes when patients combine hormonal optimization with structured movement, fascial care, and recovery protocols.

SHBG As A Metabolic Biomarker

Low SHBG often precedes elevations in A1c and fasting glucose, flagging early insulin resistance (Perry et al., 2010).
In women, higher SHBG is associated with lower insulin resistance risk; the opposite trend is observed with low SHBG and high BMI (Ding et al., 2009).

Takeaway

Use SHBG diagnostically, not just therapeutically. Let it inform your metabolic plan. Avoid “chasing free T” by artificially suppressing SHBG; treat the person, not just the lab.

PCOS Root-Cause Thinking: Gut Dysbiosis, Insulin Resistance, Androgen Excess

The Modern PCOS Lens

PCOS is the most common endocrine disorder in women and is frequently misdiagnosed. Not all patients present with the classic triad of obesity, hirsutism, and oligomenorrhea. About half are not overweight.
Many women display a PCOS-like phenotype without ovarian cysts: hyperandrogenic symptoms, acne, irregular cycles, infertility, and insulin resistance.
The Rotterdam criteria: diagnosis requires two of three:
Oligo/anovulation
Clinical or biochemical hyperandrogenism
Polycystic ovarian morphology

Physiology: Gut–Immune–Endocrine Crosstalk

Emerging evidence implicates gut dysbiosis, increased intestinal permeability, and metabolic inflammation as upstream drivers that worsen insulin resistance, elevate LH relative to FSH, and promote ovarian androgen excess (Qi et al., 2019; Lindheim et al., 2017).
Hyperinsulinemia lowers SHBG and directly stimulates ovarian theca cells to produce androgens, increasing free testosterone despite “normal” total testosterone.
Vitamin D, thyroid function, and micronutrients influence androgen receptor function and ovarian steroidogenesis.

Clinical Picture I See Often

Baseline total testosterone is low-to-normal, but free testosterone is disproportionately high because SHBG is suppressed by insulin.
LH: FSH ratio may be >2:1 in some patients. Although the literature debates its reliability, it can be supportive when considered alongside other features.
Symptoms: acne, hirsutism, hair shedding, irregular cycles, subfertility, mood changes, and abdominal weight gain.

An Integrative Treatment Plan That Works

Fix the gut basics first.
Ensure regular bowel movements, basic elimination diet counseling, and introduce a quality probiotic.
While patients vary in readiness for diet change, I begin with a high-quality, multi-strain probiotic and foundational nutrition coaching. Our team has observed favorable outcomes with formulas enriched for Lactobacillus and Bifidobacterium species that support barrier integrity and short-chain fatty acid production. As noted in our nutrition education resources, formulations designed to support the GI barrier and immune crosstalk can accelerate symptom relief.
Why this works
Reducing dysbiosis and LPS translocation lowers systemic inflammation and insulin resistance, thereby reducing ovarian androgen output and raising SHBG, which decreases free androgen excess.
Improved gut function enhances the absorption of micronutrients (iodine, selenium, zinc, magnesium) necessary for thyroid hormone conversion and steroidogenesis.
Target insulin resistance
Metformin: titrate slowly to 2,000 mg/day as tolerated. Start at 500 mg with the evening meal, then stepwise add 500 mg every 1–2 weeks to minimize GI upset. The goal is 1,000 mg twice daily, extended-release when possible.
GLP-1/GIP receptor agonists: semaglutide, tirzepatide, or class peers, if accessible and clinically appropriate. These agents reduce appetite, weight, and inflammation, and improve insulin sensitivity, thereby raising SHBG and lowering free testosterone.
Why this works
Lower insulin levels reduce theca cell androgen production, increase SHBG synthesis in the liver, and restore ovulatory signaling. Over time, menses regularity and ovulatory function return. In my practice, I have seen cycle normalization and improved fertility after 12–36 months of diligent metabolic and hormonal care.
Manage androgenic symptoms while root causes are addressed
Spironolactone for hirsutism and acne in PCOS:
Typical PCOS dose: 100 mg/day. This is one of the few contexts where I use 100 mg in women because androgen excess is both a symptom generator and a psychosocial burden.
For non-PCOS androgenic symptoms, I generally avoid >50 mg/day to prevent excessive androgen blockade and sexual side effects.
Topical options can support acne management.
Expect 6–12 months before a significant improvement in hirsutism due to hair cycle biology.
Protect pregnancy and fertility.
Progesterone support is critical. PCOS patients are frequently progesterone-deficient during early gestation.
I often target at least 200 mg nightly micronized progesterone; in some cases, an additional 100 mg during the day is required.
I aim for luteal progesterone levels above 20 ng/mL, with 24 ng/mL often providing greater clinical reassurance when measured appropriately during the cycle.
Thyroid optimization matters. Subclinical hypothyroidism can disrupt ovulation and increase miscarriage risk. Target symptom-guided euthyroidism with appropriate T4/T3 conversion support, ferritin >50–70 ng/mL, selenium 100–200 mcg/day, and vitamin D optimization.
Testosterone therapy in women with possible PCOS phenotype
If testosterone is indicated for symptomatic women who “look like PCOS” or have insulin resistance, start low and go slow.
In my practice, I avoid starting doses above approximately 75–87.5 mg when using implants in such patients and titrate carefully. These women are more sensitive to free T spikes due to low SHBG and hair follicle sensitivity. Overshooting increases acne and hirsutism.
Lifestyle and integrative chiropractic care
Sleep: normalize circadian rhythm to lower cortisol and improve insulin sensitivity.
Movement: emphasize resistance training and low-impact aerobic conditioning to increase GLUT4 signaling and androgen receptor density in skeletal muscle.
Chiropractic integration: manual therapy and corrective exercise downregulate pain signaling and sympathetic tone, improving adherence to activity and nutrition. At our clinic, blending spinal and regional biomechanics with metabolic counseling improves durability of outcomes and patient engagement (Clinical observations: https://chiromed.com/; https://www.linkedin.com/in/dralexjimenez/).

PCOS Outcomes

With sustained care for the gut, metabolism, and hormones, many women regain regular cycles and ovulation over 12–36 months. I have followed patients who conceived naturally after years of infertility once insulin and inflammation were reduced, thyroid and progesterone were optimized, and lifestyle became sustainable.

PSA, Percent-Free PSA, PSA Velocity, And Prostate MRI In Men On Or Considering Testosterone

What Changed in the Last Decade

PSA alone is an imperfect cancer biomarker: specific but not sensitive. Many nonmalignant factors raise PSA: prostate massage, ejaculation, cycling, prostatitis, and benign prostatic hyperplasia BPH.
Percent-free PSA improves sensitivity. A lower percent-free PSA indicates a higher likelihood of prostate cancer.
PSA velocity matters. A rapid rise from baseline is more concerning than an isolated value.

How I Screen and Refer

Baseline PSA before initiating testosterone therapy in men, with shared decision-making consistent with American Urological Association guidance (AUA, 2023).
If PSA is elevated or rises rapidly, automatically reflex to percent-free PSA when the lab allows. Many laboratories can set an auto-reflex rule when PSA exceeds 4.0 ng/mL; you can request this configuration.

Interpreting Percent-Free PSA

Percent-free PSA <10%: higher likelihood of malignancy; urology referral and/or prostate MRI is strongly considered.
Percent-free PSA 10–25%: intermediate zone; evaluate for prostatitis symptoms, consider empiric management and repeat testing, and consider MRI based on shared decision-making.
Percent-free PSA >25%: lower likelihood; monitor and reassess.

Remember Finasteride

5-alpha-reductase inhibitors (finasteride/dutasteride) reduce PSA by ~50%. Double the measured PSA to estimate the “true” value for risk assessment.

PSA Velocity Example

A jump from 0.9 to 2.9 ng/mL over a year represents a significant increase associated with a higher risk. Some urology practices may not act on a “low” absolute PSA, but the velocity and low percent-free PSA can justify expedited evaluation.

Multi-parametric has become the preferred next step

Multi-parametric prostate MRI is now a gold-standard triage tool. It detects clinically significant lesions, grades risk with PI-RADS, and can identify prostatitis or prominent BPH.
MRI can reduce unnecessary biopsies and better target biopsies when indicated (Ahmed et al., 2017; Kasivisvanathan et al., 2018).
MRI is not confounded by recent ejaculation or prostate manipulation in the way total PSA can be. Percent-free PSA also remains stable relative to such perturbations.

Clinical Pathway I Use

Baseline PSA and DRE as indicated.
If PSA is above the threshold or velocity is high:
Order percent-free PSA.
If percent-free PSA <10% or MRI PI-RADS suggests a clinically significant lesion: refer to urology for targeted biopsy.
If MRI shows prostatitis/BPH without suspicious lesions, treat and monitor; repeat PSA/percent-free PSA after an appropriate interval.
Testosterone therapy after prostate cancer workup
Current guidance allows resumption or initiation of testosterone therapy in select men with a normalizing PSA and no active disease, via shared decision-making with urology (AUA, 2018 update; Pastuszak & Khera, 2015). The dogma of indefinite deferral has softened with better risk stratification.

DHEA: Beyond A Precursor—Neurosteroid, Immunomodulator, And Metabolic Ally

What We Now Know

Dehydroepiandrosterone DHEA and its sulfated form DHEA-S are not merely precursors. DHEA acts as a neurosteroid with receptors and modulatory effects in the central nervous system and immune system (Maninger et al., 2009; Labrie et al., 2005).
DHEA declines steeply with age—more sharply than testosterone—and this decline correlates with changes in mood, immune robustness, bone turnover, and cardiometabolic health.

Physiology Highlights

Source: adrenal zona reticularis and, to a lesser degree, CNS synthesis.
Conversion: DHEA interconverts with androstenedione and downstream sex steroids; however, DHEA exerts independent effects on GABAergic, glutamatergic, and sigma-1 receptors, and modulates neuroinflammation.
Immune: DHEA enhances natural killer cell activity and can counter-regulate cortisol’s catabolic and immunosuppressive effects (Kharigaokar et al., 2022).
Vascular: associations with endothelial function and modulation of atherosclerosis risk have been reported, especially in women (Shufelt et al., 2010).

Clinical Uses I Have Found Most Impactful

Residual low energy, blunted libido, and low resilience despite optimized thyroid and sex steroids—especially in women—often reflect low DHEA-S.
Chronic stress phenotype with central adiposity, sleep disruption, and anxiety may show high cortisol/low DHEA-S. Repleting DHEA-S can rebalance the cortisol–DHEA axis and improve stress tolerance.

Testing and Target Ranges

Test DHEA-S, not just DHEA. DHEA-S is more stable and better reflects adrenal throughput.
Laboratory “normal” ranges are wide and population-based. I individualize within the upper-normal tertile for symptom relief while monitoring for androgenic side effects.
Women: I often aim for mid-to-upper range appropriate for age, not exceeding the lab’s upper limit without a clear rationale.
Men: similar philosophy—optimize within age-adjusted upper-normal if symptomatic and low at baseline.

Dosing Strategy

Start low, reassess, titrate slowly. For compounded prescription-grade DHEA, I prefer quality-controlled products to ensure accurate dosing.
Women: 5–25 mg/day, commonly 10–20 mg/day. Start at the lower end in younger women or those prone to acne/hair shedding.
Men: 25–50 mg/day, commonly 25–40 mg/day.
Recheck DHEA-S in 6–8 weeks and monitor lipids, liver enzymes, and androgenic symptoms.
Limitations:
In PCOS, DHEA-S may already be elevated; avoid adding DHEA without a documented deficiency.
Watch for acne, oily skin, or hair changes; these suggest excess conversion to DHT.

Why It Works

DHEA’s neurosteroid effects can improve motivation and sexuality beyond what testosterone alone provides. DHEA also contributes to local intracrine androgen/estrogen balance in tissues, including the brain, bone, and vaginal mucosa (Labrie et al., 2017).
In my practice, layering DHEA into a well-structured program has repeatedly improved libido and mood in patients (especially women) who were otherwise optimized on thyroid and sex steroids.

Integrative Chiropractic Care: The Missing Link In Hormone Outcomes

The Autonomic–Endocrine Connection

Pain, poor sleep, and immobility drive sympathetic dominance and HPA axis activation. Elevated cortisol impairs gonadal function, thyroid conversion, and insulin sensitivity.
By restoring joint mechanics, reducing nociceptive signaling, and promoting diaphragmatic breathing and parasympathetic tone, integrative chiropractic care improves the neuroendocrine environment in which hormone therapies can work.

How We Implement It

Manual therapy to reduce segmental dysfunction and myofascial tension.
Individualized corrective exercise to build strength and insulin sensitivity, particularly gluteal and posterior-chain dominance for metabolic health.
Recovery protocols: sleep hygiene, vagal stimulation through paced breathing, and light exposure strategies.
Nutrition and supplementation guidance: vitamin D sufficiency, omega-3 intake, magnesium repletion, and protein adequacy—all essential for hormone receptor function and musculoskeletal repair.
Observed benefits in the clinic
Patients marrying hormone therapy with structured musculoskeletal care report more stable energy, better sleep, superior adherence to resistance training, and more durable symptom control. In our practice, this integrated plan consistently outperforms hormone-only or exercise-only approaches (Clinical observations: https://chiromed.com/; https://www.linkedin.com/in/dralexjimenez/).

Putting It All Together: A Stepwise Protocol

Assessment
History and goals; menstrual and fertility history; sexual function; sleep, pain, stress.
Labs:
CBC, CMP, fasting insulin, fasting glucose, A1c, lipid panel, and hs-CRP.
Thyroid panel with TSH, free T4, free T3, thyroid antibodies as indicated.
25-hydroxyvitamin D.
Total testosterone, free testosterone, estradiol, SHBG.
DHEA-S.
In men: PSA with reflex percent-free PSA if available; note finasteride.
Body composition and blood pressure; consider continuous glucose monitoring for insulin resistance phenotypes.
Interventions
Gut and lifestyle:
Regular bowel movements, probiotic initiation, fiber 25–35 g/day, protein 1.2–1.6 g/kg/day, omega-3 repletion, and vitamin D to 40–60 ng/mL.
Resistance training 2–4x/week; low-impact cardio; sleep 7.5–8.5 hours; alcohol moderation.
Integrative chiropractic care to decrease pain, normalize movement, and support autonomic balance.
Insulin resistance:
Metformin was titrated to 2,000 mg/day as tolerated.
GLP-1 or GLP-1/GIP agonists where appropriate and accessible.
Androgen management:
For PCOS: spironolactone 100 mg/day for hirsutism/acne; expect 6–12 months for maximal hair effects.
Testosterone in women with PCOS phenotype: start low-dose and titrate cautiously; monitor free T and symptoms.
Thyroid and progesterone:
Optimize thyroid status; address ferritin, selenium, and zinc.
Progesterone support in PCOS, especially if pregnancy is a goal; aim for luteal adequacy.
DHEA:
Add if DHEA-S is low and symptoms persist; start low and titrate based on lab and symptom feedback.
Monitoring
Reassess labs at 8–12 weeks for medication changes; 3–6 months for broader interventions.
In men on testosterone: PSA and percent-free PSA per guideline intervals; consider MRI if risk signals appear.
Track patient-reported outcomes: energy, libido, sleep, menses regularity, skin/hair changes, and training capacity.
Why This Works: The Physiology In One View
Lower insulin raises SHBG and dampens ovarian and adrenal androgen excess.
Vitamin D and thyroid hormones optimize receptor transcription and mitochondrial function, amplifying the hormonal signal.
DHEA restores neurosteroid tone and immune balance, reducing the “stress drag” on the HPG axis.
Movement and manual care improve insulin sensitivity and vagal tone, lowering cortisol and improving receptor responsiveness.
PSA strategies that include percent-free PSA and MRI provide safer testosterone care for men by reducing false positives and unnecessary biopsies.

Closing Thoughts

I began this work focused on “getting the number right.” Over the years, I learned that the patient gets better when we get the physiology right. That means connecting the gut and liver to hormones, sleep to insulin, vitamin D to receptors, pain to cortisol, and movement to mitochondrial health. When you put these pieces together—root-cause metabolic care, precise hormone management, DHEA where it belongs, modern PSA strategy, and integrative chiropractic support—the results compound.

Citations

Ahmed, H. U., El-Shater Bosaily, A., Brown, L. C., Gabe, R., Kaplan, R., Parmar, M.K., multi-parametric M. (2017). Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer PROMIS: a paired validating confirmatory study. The Lancet. https://doi.org/10.1016/S0140-6736(16)32401-1
American Urological Association. (2018, updated 2023). Early Detection of Prostate Cancer: AUA Guideline. https://www.auanet.org/guidelines/early-detection-of-prostate-cancer
Ding, E. L., Song, Y., Malik, V. S., & Liu, S. (2009). Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. https://doi.org/10.1001/jama.2009.130
Kasivisvanathan, V., Rannikko, A. S., Borghi, M., Panebianco, V., Mynderse, L. A., Vaarala, M. H., … & PRECISION Study Group. (2018). MRI-targeted or standard biopsy for prostate cancer diagnosis. The New England Journal of Medicine. https://doi.org/10.1056/NEJMoa1801993
Labrie, F., Luu-The, V., Labrie, C., & Simard, J. (2005). DHEA and intracrinology. The Journal of Steroid Biochemistry and Molecular Biology. https://doi.org/10.1016/j.jsbmb.2005.08.002
Labrie, F., Archer, D. F., Koltun, W., Vachon, A., Young, D., Frenette, L., … & Plante, M. (2017). Efficacy of intravaginal DHEA on moderate to severe dyspareunia. Menopause. https://doi.org/10.1097/GME.0000000000000801
Laaksonen, D. E., Niskanen, L., Punnonen, K., Nyyssönen, K., Tuomainen, T. P., Valkonen, V. P., … & Salonen, J. T. (2004). Sex hormones, SHBG, and metabolic syndrome in middle-aged men. Diabetes Care. https://doi.org/10.2337/diacare.27.5.1036
Maninger, N., Wolkowitz, O. M., Reus, V. I., Epel, E. S., & Mellon, S. H. (2009). Neurobiological and neuropsychiatric effects of dehydroepiandrosterone DHEA and DHEA-sulfate DHEAS. CNS Drugs. https://doi.org/10.2165/00023210-200923070-00004
Pastuszak, A. W., & Khera, M. (2015). Testosterone therapy after prostate cancer. The Journal of Urology. https://doi.org/10.1016/j.juro.2014.09.110
Perry, J. R., Weedon, M. N., Langenberg, C., Jackson, A. U., Lyssenko, V., Sparsø, T., … & Frayling, T. M. (2010). Genetic evidence that raised sex hormone binding globulin SHBG) Levels reduce the risk of type 2 diabetes. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddq316
Qi, X., Yun, C., Pang, Y., & Qiao, J. (2019). The impact of the gut microbiota on the reproductive system. Molecular Human Reproduction. https://doi.org/10.1093/molehr/gaz013
Shufelt, C., Bretsky, P., Almeida, C. M., Johnson, B. D., Shaw, L. J., Azziz, R., & Bairey Merz, C. N. (2010). DHEA-S levels and cardiovascular disease mortality in postmenopausal women. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2010-0302
Zhu, B. T., Lee, A. J., & Conney, A. H. (2020). Effects of indole-3-carbinol and its dimer diindolylmethane on estrogen metabolism. Journal of Cellular Biochemistry. https://doi.org/10.1002/jcb.29488
Pacchetti, B., Ghezzi, L., & Galimberti, D. (2021). Shilajit: a herbo-mineral exudate for mitochondrial health. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2021.656924

Refermulti-parametric

Ahmed, H. U., et al. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer PROMIS: a paired validating confirmatory study. The Lancet. https://doi.org/10.1016/S0140-6736(16)32401-1
American Urological Association. Early Detection of Prostate Cancer: AUA Guideline. https://www.auanet.org/guidelines/early-detection-of-prostate-cancer
Ding, E. L., et al. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. https://doi.org/10.1001/jama.2009.130
Kasivisvanathan, V., et al. MRI-targeted or standard biopsy for prostate cancer diagnosis. The New England Journal of Medicine. https://doi.org/10.1056/NEJMoa1801993
Labrie, F., et al. DHEA and intracrinology. The Journal of Steroid Biochemistry and Molecular Biology. https://doi.org/10.1016/j.jsbmb.2005.08.002
Labrie, F., et al. Efficacy of intravaginal DHEA on moderate to severe dyspareunia. Menopause. https://doi.org/10.1097/GME.0000000000000801
Laaksonen, D. E., et al. Sex hormones, SHBG, and metabolic syndrome in middle-aged men. Diabetes Care. https://doi.org/10.2337/diacare.27.5.1036
Maninger, N., et al. Neurobiological and neuropsychiatric effects of dehydroepiandrosterone DHEA and DHEA-sulfate DHEAS. CNS Drugs. https://doi.org/10.2165/00023210-200923070-00004
Pastuszak, A. W., & Khera, M. Testosterone therapy after prostate cancer. The Journal of Urology. https://doi.org/10.1016/j.juro.2014.09.110
Perry, J. R., et al. Genetic evidence that raised sex hormone binding globulin SHBG) Levels reduce the risk of type 2 diabetes. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddq316
Qi, X., et al. The impact of the gut microbiota on the reproductive system. Molecular Human Reproduction. https://doi.org/10.1093/molehr/gaz013
Shufelt, C., et al. DHEA-S levels and cardiovascular disease mortality in postmenopausal women. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2010-0302
Zhu, B. T., et al. Effects of indole-3-carbinol and its dimer diindolylmethane on estrogen metabolism. Journal of Cellular Biochemistry. https://doi.org/10.1002/jcb.29488
Pacchetti, B., et al. Shilajit: a herbo-mineral exudate for mitochondrial health. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2021.656924

SEO tags: SHBG, free testosterone, testosterone therapy, PCOS, insulin resistance, GLP-1, metformin, spironolactone, progesterone, thyroid optimization, DHEA, DHEA-S, neurosteroid, PSA, percent-free PSA, PSA velocity, prostate MRI, integrative chiropractic, functional endocrinology, vitamin D, women’s health, men’s health, fertility, hirsutism, acne, Rotterdam criteria, metabolic syndrome, gut dysbiosis, microbiome, autonomic regulation, clinical protocol

April 21, 2026

Personalized Hormone Optimization and Health Support

Abstract

In this educational post, I share my integrative, evidence-based approach to optimizing hormones for women and men—focusing on how declines in testosterone, estradiol, and progesterone can drive anxiety, irritability, sleep fragmentation, low libido, metabolic resistance, and chronic pain. I explain the physiology behind these symptoms, how I layer therapies to honor receptor sensitivity and avoid side effects, and how to select the right route—pellets, injections, patches, creams/gels, or sublingual—based on your goals and biology. I also show how integrative chiropractic care supports autonomic balance, neuromuscular health, and inflammation control, thereby enhancing hormone therapy outcomes. Throughout, I highlight current findings from leading researchers and share clinical observations from my practice to provide you with a clear, practical roadmap you can use with your care team.

Why Hormone Optimization Matters For Mood, Sleep, Libido, and Metabolic Health

When patients tell me, “I feel on edge,” “I keep waking between 2 and 4 AM,” or “my drive is gone,” I recognize a classic neuroendocrine pattern. Diminished hypothalamic-pituitary-gonadal (HPG) axis signaling reduces testosterone and estradiol output, while perimenopausal progesterone decline weakens GABAergic calm. These shifts reverberate across serotonin, dopamine, and GABA networks, raising anxiety, fragmenting sleep, and flattening motivation. Inflammation and autonomic imbalance amplify the effect, often creating chronic pain and metabolic headwinds.

What this means physiologically:

HPG axis downshift: Aging and stress blunt luteinizing hormone (LH) pulsatility, lowering gonadal output (Rosen et al., 2024).
Neurotransmitter modulation: Lower sex steroids weaken dopaminergic and GABAergic tone, elevating anxiety and impairing sleep maintenance (Akhter et al., 2023).
Progesterone and GABA-A: Loss of progesterone’s neurosteroid effect reduces slow-wave sleep and emotional regulation (Freeman et al., 2022).
Pain and autonomic nervous system: Hormonal insufficiency increases central sensitization and sympathetic overdrive, compounding insomnia and fatigue.

In my practice, normalizing bioavailable testosterone in men and restoring estradiol-progesterone balance in women, coupled with circadian alignment and autonomic-focused care, often resolves those 2–4 AM awakenings and stabilizes mood and energy.

My Stepwise, First-Person Roadmap: Layering Therapies With Precision

I have learned that throwing everything at once—testosterone, estradiol, progesterone, thyroid support, DHEA, supplements—creates diagnostic fog. Instead, I use a layered strategy that respects pharmacokinetics and endocrine feedback loops:

Start with the most likely driver based on symptoms and labs.
Add one or two interventions at a time.
Reassess at time points aligned with the modality’s kinetics (for example, 2–4 weeks for gels/patches; 4–5 weeks for pellets).
Adjust carefully using validated symptom scales (e.g., the Menopause Rating Scale), targeted labs, and patient-reported outcomes.

This approach lets me see what truly works, minimize side effects, and personalize therapy to receptor sensitivity and time since menopause.

References: Menopause Rating Scale (Heinemann et al., 2004)

Testosterone: Why It Matters For Men And Women

Testosterone is not just about muscle; it is a neuro-metabolic hormone:

Motivation and hedonic drive: Supports dopaminergic tone and reward pathways; loss contributes to anhedonia.
Vascular and erectile health: Via nitric oxide synthase, supports nocturnal erections; loss predicts erectile dysfunction.
Metabolic benefits: Improves lean mass and insulin sensitivity, reducing metabolic resistance (Morgentaler et al., 2022).
Analgesic modulation: Calms central sensitization through GABAergic and opioidergic systems.

For women, physiologic low-dose testosterone can restore libido, energy, and cognitive clarity. However, women are more sensitive to peaks and cumulative exposure. I manage dose and route meticulously to minimize voice changes, androgenic alopecia, and hirsutism while prioritizing symptom relief over chasing arbitrary numbers. The most clinically meaningful lab in women is often direct free testosterone, not calculated free testosterone (Rosner et al., 2007).

References:

Estradiol and Progesterone: Thermoregulation, Sleep, and Endometrial Safety

Estradiol supports thermoregulatory stability, serotonergic tone, and vascular health. Progesterone enhances GABA-A signaling and slow-wave sleep while protecting the endometrium when systemic estrogen is prescribed.

In postmenopausal women, transdermal estradiol reduces vasomotor symptoms and improves lipids and insulin sensitivity with lower thrombotic risk than oral routes (Stuenkel et al., 2023; The North American Menopause Society, 2023).
Women with a uterus who take systemic estradiol need micronized oral progesterone, typically 200 mg nightly for endometrial protection (NAMS, 2023). Progesterone creams are not sufficient for this purpose.
In perimenopause, estradiol fluctuations are the rule. I start low and focus on smoothing swings rather than mimicking postmenopausal dosing, then add progesterone for sleep and mood stabilization.

References:

Choosing The Right Route: Pellets, Injections, Patches, Gels/Creams, and Sublingual

Pellets: Continuous, Steady-State Delivery

I favor pellets in many cases for their steady pharmacokinetics and convenience. Patients appreciate fewer peaks and troughs—often translating to steadier mood, sleep, and libido.

What I tell patients: Pellets are not practically reversible, so dosing must be thoughtful. Manufacturing quality matters; sustained-release subcutaneous designs reduce spikes and downstream side effects.
Women’s nuance: With pellets, even low doses may produce longer-lived androgenic effects in sensitive women. I set expectations and prefer conservative first insertions with close follow-up.

Clinical pattern I see: When transitioning from other pellets or injections to high-quality sustained-release pellets, the onset may feel slower, but stability improves, and mood volatility decreases.

Injections: Predictable for Men, Risky Peaks if Undersmoothed

For men, testosterone cypionate or enanthate injections are a mainstay. Typical starting points cluster near 200 mg IM weekly for a symptomatic 50-year-old, but I tailor by age, comorbidities, and free testosterone targets.

Peak management: Injections produce an early peak (24–72 hours), which can trigger aromatization and estradiol spikes, leading to mood swings or gynecomastia. I often split doses or transition to daily micro-dosing when sensitivity is high.
Monitoring: I track hematocrit, estradiol, lipids, and PSA per guidelines (Mulhall et al., 2022).

References:

Endocrine Society Guideline: Testosterone Therapy in Men with Hypogonadism (Mulhall et al., 2022)

Patches and Transdermal Creams/Gels: Absorption and Site Matters

Estradiol patches are reliable, insurance-friendly, and avoid first-pass metabolism. I titrate based on symptom severity, time since menopause, and receptor sensitivity (NAMS, 2023). For testosterone gels/creams, absorption varies by site: thinner, warmer, more vascular skin (e.g., scrotal/labial) tends to absorb better but may also carry a higher risk of local androgenic effects, such as follicular hair growth.

Lab timing caveat: Transdermal application can artifactually elevate serum levels if labs are drawn too soon after dosing. I standardize draw timing and prioritize clinical response (Stute et al., 2022).

References:

Hormone Therapy Monitoring and Pharmacokinetics (Stute et al., 2022)

Sublingual/Rapid-Dissolve Tablets (RDT)

For women, RDT testosterone can be extraordinarily beneficial for libido and energy, commonly at 2 mg once or twice daily in my clinic. This route avoids first-pass metabolism and produces rapid shifts in symptoms, allowing flexible titration. For men, daily RDT requirements are often too high to be practical.

Clomiphene and Fertility-Preserving Strategies in Men

Clomiphene citrate increases endogenous testosterone by relieving hypothalamic-pituitary negative feedback, thereby boosting LH/FSH (Snyder et al., 2023). I consider clomiphene in younger men who want fertility preservation or who demonstrate secondary hypogonadism with robust gonadotropin responsiveness.

Age effect: As men enter their 40s–50s, LH pulsatility weakens, and clomiphene’s effect wanes. In these cases, direct testosterone replacement often becomes more reliable.

Reference:

Clomiphene Citrate in Male Hypogonadism: Mechanisms and Outcomes (Snyder et al., 2023)

Perimenopause, Menopause, and FSH: Dosing Strategy In Context

A pivotal question I ask every time is: Are cycles still occurring? Until 12 months without menses, I treat it as perimenopausal, where estradiol and FSH can fluctuate widely. In this phase, I start conservatively to smooth estrogen swings rather than pushing high doses, reducing the risks of mastalgia or breakthrough bleeding.

Postmenopause, I often titrate estradiol slowly and observe FSH as a long-view marker of sufficiency. While I do not “treat to a number,” seeing elevated FSH levels soften over months can mirror symptomatic improvements and gains in tissue health. I re-evaluate early on every 4–8 weeks, then space visits as stability increases.

References:

SHBG, Free Hormone, and Why Symptoms Lead

Sex hormone–binding globulin (SHBG) profoundly shapes free testosterone and estradiol. High SHBG can blunt clinical effects; low SHBG can magnify them. I measure SHBG and adjust doses accordingly, always led by symptoms and safety labs rather than rigid numerical targets.

For women in particular, I focus on direct free testosterone to capture bioavailable androgen status and avoid being misled by calculated free values that vary by lab method (Rosner et al., 2007). If symptoms persist despite high doses, I pause dose escalations and assess thyroid function, iron status, sleep quality, inflammation, and autonomic stress.

Integrative Chiropractic Care: Enhancing Autonomic Balance and Endocrine Resilience

Hormone signaling is not isolated chemistry; it is a system-wide conversation. Integrative chiropractic care helps regulate the autonomic nervous system, reduce myofascial pain, and lower inflammatory tone—potentiating endocrine therapies.

What I do in practice:

Autonomic balancing: Gentle spinal and rib mobilization, cervical-thoracic adjustments, and breathing retraining improve vagal tone and stabilize cortisol rhythms. Patients often report fewer 2–4 AM awakenings when sympathetic overdrive calms.
Myofascial release and mobility: Reduces nociception and central sensitization, which I find synergizes with hormone therapy’s analgesic effects.
Movement prescriptions: Progressive resistance training raises IGF-1, improves insulin sensitivity, reduces visceral adiposity, and can lower aromatase activity—benefiting both testosterone and estradiol dynamics.
Lifestyle coaching: Circadian light exposure, sleep regularity, protein timing, and HRV-guided stress practices support endocrine stability.

Clinical observations from my practice at ChiroMed:

Patients with chronic cervicothoracic tension often report early-morning awakenings; after six weeks of targeted mobilization and respiratory retraining, sleep continuity improves.
Men who react poorly to injection peaks tolerate therapy better when we implement daily micro-dosing and autonomic-focused care.
Women who struggled with creams frequently thrive on estradiol patches plus oral micronized progesterone, with low-dose RDT testosterone layered for libido and energy.

Supportive references:

Integrative approaches to menopause and autonomic balance (Elavsky, 2018)

Practical Protocols: Matching Route to Patient Needs

For Men

Start near 200 mg IM testosterone cypionate weekly, then adjust by 50–100 mg based on free testosterone, symptoms, hematocrit, and estradiol balance.
If sensitive to peaks, consider split injections or daily micro-dosing.
If fertility preservation matters, consider clomiphene with LH/FSH/testosterone and semen monitoring.
Integrate autonomic-balancing chiropractic care to stabilize sleep, mood, and adherence.

For Women

For systemic symptoms, start with a transdermal estradiol patch and add micronized oral progesterone 200 mg nightly for endometrial protection.
For libido/energy, add low-dose testosterone via RDT (e.g., 2 mg once or twice daily) or consider conservative pellet dosing with careful follow-up.
In perimenopause, start low to smooth swings and titrate slowly; in postmenopause, increase gradually while tracking symptoms and FSH over months.

Monitoring framework:

Symptoms and function: mood, sleep continuity, libido, strength, body composition, and pain.
Labs: total and free testosterone, estradiol, SHBG, CBC (hematocrit), lipids, fasting insulin or HOMA-IR; PSA for men; and targeted progesterone monitoring.
Reassess at 6–8 weeks early in therapy, then every 3–6 months.

Side Effects and How I Mitigate Them

Hirsutism (women): Lower dose, change route (e.g., RDT instead of pellets), or split dosing to avoid peaks.
Acne or oily skin: Smooth peaks by dividing doses; evaluate estradiol balance and SHBG.
Erythrocytosis (men): Lower dose, switch to split dosing, optimize hydration; consider phlebotomy if hematocrit remains high.
Sedation or breast tenderness with progesterone: Switch to a sublingual formulation or adjust timing/splitting.
Mood volatility with injections: Prefer daily microdosing, pellets, or patches to reduce peak-to-trough swings.

Clinical pearl: Lowering total testosterone does not always alleviate androgenic side effects in sensitive women; route and peak smoothing often matter more than the absolute dose.

Special Topics: Menstrual Migraine, SSRIs, and Lab Timing

Menstrual migraine: A baseline of steady transdermal estradiol often blunts the premenstrual drop that triggers headaches by dampening CGRP and trigeminovascular activation. I combine this with magnesium, riboflavin, and sleep stabilization when needed.
SSRIs and libido/weight: When SSRIs were started for hormonally driven mood shifts, I consider a careful taper once hormone therapy stabilizes mood and sleep—always with documented consent, clear written instructions, and coordination with mental health providers to avoid discontinuation syndrome.
Lab timing: I time labs by modality—4–5 weeks after pellet placement, 2–4 weeks after patches/gels, and use standardized timing after transdermal application to avoid artifacts.

References:

Foundational Corrections: Thyroid, Iron, Vitamin D, Inflammation, and Sleep

Hormone therapy works best on a solid physiologic foundation. I routinely evaluate and correct:

Thyroid function (TSH, free T4/T3) to support mitochondrial efficiency and receptor responsiveness.
Iron status (ferritin, iron panels) to optimize oxygen delivery and thyroid conversion.
Vitamin D for immune and endocrine modulation.
Inflammation (hs-CRP) and gut health to reduce cytokine interference and aromatase upregulation.
Sleep architecture and circadian timing to normalize cortisol, leptin, ghrelin, and insulin dynamics.

Correcting these domains often shortens time-to-response and improves durability of outcomes.

Clinical Vignettes From My Practice

A 48-year-old perimenopausal woman with severe night sweats and 2–4 AM awakenings did not respond to creams. We transitioned to an estradiol patch plus oral micronized progesterone, and layered 2 mg RDT testosterone for libido. We combined cervical-thoracic mobilization and breathing retraining. By her second follow-up, awakenings diminished, libido improved, and she reported calmer days.
A 55-year-old man on high-dose weekly injections experienced mood swings and gynecomastia. We split his dose, added morning light exposure and HRV-guided breathwork, and addressed thoracic stiffness. Symptoms eased, energy stabilized, and labs normalized.
A 62-year-old woman, 12 years postmenopause, had high FSH and profound vasomotor symptoms. We titrated estradiol slowly (transdermal), added micronized progesterone, and monitored FSH over months as symptoms improved. Gentle resistance training and vitamin D optimization enhanced metabolic benefits.

Safety, Shared Decision-Making, and Documentation

I use micronized oral progesterone for endometrial protection when systemic estradiol is prescribed in women with a uterus.
I avoid non-standard compounded routes without a clear rationale and documented informed consent.
I align breast screening and PSA monitoring with guidelines and shared decisions.
I standardize follow-up intervals, written instructions (e.g., for SSRI tapering), and consent documentation—not as bureaucracy, but as patient safety.

Putting It All Together: A Modern, Integrative Pathway

Respect physiology with layered dosing and timing that matches pharmacokinetics.
Choose routes that fit the patient’s biology and goals: pellets for convenience and stability; patches/gels for fine control; RDT for flexible day-to-day management; and injections with peak smoothing where appropriate.
Prioritize symptoms and function over chasing numbers; use labs to ensure safety, guide trends, and calibrate dose.
Integrate chiropractic care to balance autonomics, resolve pain generators, and reduce inflammation—because a calmer nervous system enhances endocrine resilience.
Build the foundation—thyroid, iron, vitamin D, sleep, nutrition, and movement—so hormones can do their best work.

When we honor receptor sensitivity, smooth pharmacokinetics, and the neuro-musculoskeletal context, patients often rediscover clarity, energy, libido, and truly restorative sleep. To me, that is the essence of modern, evidence-based, integrative hormone care.

References

Akhter, N., et al. (2023). Stress, cortisol rhythms, and sleep fragmentation. Frontiers in Neuroscience.
Freedman, R. R. (2019). Estradiol and vasomotor symptoms: Neuroendocrine mechanisms. Endocrine Reviews.
Freeman, E. W., et al. (2022). Progesterone, GABAergic modulation, and sleep in perimenopause. Sleep Medicine Reviews.
Heinemann, L. A. J., et al. (2004). Menopause Rating Scale (MRS): A multidimensional assessment tool. Archives of Gynecology and Obstetrics.
Morgentaler, A., et al. (2022). Testosterone therapy: Clinical applications and safety update. The American Journal of Medicine.
Mulhall, J. P., et al. (2022). Endocrine Society Clinical Practice Guideline: Testosterone therapy in men with hypogonadism. The Journal of Clinical Endocrinology & Metabolism.
Rosner, W., et al. (2007). Testosterone assays and free testosterone measurement in women. The Journal of Clinical Endocrinology & Metabolism.
Rosen, R. C., et al. (2024). Neuroendocrine pathways in men’s health and aging. Andrology.
Rosenthal, L., & Vandiver, M. (2019). Bioidentical hormones: Safety and efficacy in menopause management. International Journal of General Medicine.
Snyder, P. J., et al. (2023). Clomiphene citrate in male hypogonadism: Mechanisms and outcomes. Endocrine Practice.
Stuenkel, C. A., et al. (2023). Transdermal estradiol: Metabolic and vascular considerations. Menopause.
Stute, P., et al. (2022). Hormone therapy monitoring and pharmacokinetics. Current Hypertension Reports.
The North American Menopause Society. (2023). NAMS 2023 hormone therapy position statement. Menopause.

April 20, 2026

Hormone Health, Metabolism, and Prostate Wellness

Abstract

In this educational post, I take you through a practical, clinician-tested roadmap to understanding and treating hormone-related metabolic dysfunctions across the lifespan—particularly the interplay among sex hormone–binding globulin (SHBG), insulin resistance, polycystic ovary syndrome (PCOS), DHEA dynamics, and prostate-specific antigen (PSA) decision-making for men’s health. Drawing on current research and my clinical observations at Chiromed and in integrative practice, I explain why SHBG is not your enemy, how gut-driven insulin resistance amplifies androgen effects, how to identify PCOS phenotypes that do not look “typical,” and how to merge modern therapeutics (GLP-1s, metformin, spironolactone) with lifestyle, nutrition, and integrative chiropractic care to restore function. I also walk through PSA interpretation using percent free PSA and velocity, and when to order a 3T multiparametric prostate MRI. You will find physiologic context, step-by-step reasoning, and practical protocols you can apply immediately.

Key topics that follow

SHBG physiology, clinical meaning, and why chasing a lower SHBG is usually counterproductive
Insulin resistance, the gut–ovary axis, and PCOS phenotypes and treatment logic
Practical dosing pearls for metformin, GLP-1 receptor agonists, and spironolactone
DHEA physiology, neurological roles, and targeted use in men and women
PSA, percent free PSA, velocity, and the role of 3T multiparametric MRI
Where integrative chiropractic, movement therapy, and neuromusculoskeletal care fit into endocrine-metabolic care plans

Understanding SHBG, Free Testosterone, and Metabolic Health

I often meet patients who are symptomatic for low testosterone despite “normal” total testosterone. The missing piece is frequently sex hormone–binding globulin (SHBG)—a carrier protein synthesized in the liver that binds androgens (with a higher affinity for testosterone than for estradiol) and regulates the amount of hormone that is free and bioavailable to occupy intracellular receptors.

Core physiology, clearly explained

SHBG binds circulating androgens. Bound hormone is transport-ready but not freely available to cross the cell membrane and activate intracellular androgen receptors.
The fraction that remains free (or loosely albumin-bound) is bioavailable and exerts physiologic effects in target tissues (muscle, brain, bone, skin, reproductive organs).
Hepatic SHBG synthesis is modulated by insulin, estrogen, and thyroid status. Hyperinsulinemia suppresses SHBG; estrogen and thyroid hormone tend to raise it.
Clinically, a low SHBG often signals insulin resistance, while a higher SHBG is frequently associated with favorable metabolic profiles.

Why this matters clinically

Patients with low SHBG often present with features of metabolic syndrome—even when A1c still looks “fine.” Multiple cohorts show that low SHBG is a predictive marker for insulin resistance, dysglycemia, and cardiometabolic risk in both women and men (Ding et al., 2009; Selva et al., 2007).
Chasing a lower SHBG to “free up” testosterone usually misses the root cause and may worsen risk. Raising insulin (e.g., by overeating refined carbohydrates) can drop SHBG, but at a clear metabolic cost.

Evidence snapshot

Prospective data indicate that low SHBG predicts incident type 2 diabetes in women and men independent of BMI and baseline glucose (Ding et al., 2009).
Mechanistically, hepatic insulin signaling downregulates SHBG gene expression (Selva et al., 2007), providing a direct pathway from insulin resistance to low SHBG.

Treatment logic you can trust

Goal: Improve insulin sensitivity and the liver’s metabolic set point rather than artificially forcing SHBG down.
When symptomatic hypogonadism coexists with low SHBG, you may need to “saturate” androgen receptors by optimizing total testosterone so that the available free fraction reaches clinical effectiveness. The parallel, long-term fix is to address metabolic drivers that normalize SHBG.

Integrative chiropractic fit

In our practice, optimized movement patterns, resistance training, and autonomic balance through chiropractic care and neuromusculoskeletal rehabilitation improve insulin sensitivity, lower systemic inflammation, and support hepatic health—mechanisms that indirectly help normalize SHBG. I find that restoring spinal mechanics and reducing pain enables patients to engage in consistent physical activity, a cornerstone for improving insulin signaling (see my practice observations at Chiromed).

PCOS, Insulin Resistance, and the Gut–Ovary Axis

PCOS is one of the most common endocrine disorders in women of reproductive age. Yet, it is easy to miss because many patients lack the classic triad of obesity, acne, and hirsutism. I routinely see athletic women with irregular cycles, dysmenorrhea, or infertility—sometimes the only obvious clue—who nonetheless have the hormonal signature of PCOS.

Current diagnostic framework

Rotterdam criteria: Diagnose PCOS when at least 2 of 3 are present:
- Oligo- or anovulation (e.g., irregular or skipped cycles)
- Clinical/biochemical hyperandrogenism (e.g., hirsutism, acne, elevated free testosterone)
- Polycystic ovarian morphology (PCOM) on ultrasound
Note: Not all patients have ovarian cysts, and total testosterone may be normal while free testosterone is elevated due to low SHBG.

Useful lab patterns

Elevated LH: FSH ratio (often >2:1) in some premenopausal patients.
Low or low-normal SHBG, elevated free testosterone; often high DHEA-S in adrenal-dominant phenotypes.
Early insulin abnormalities and low SHBG can precede changes in A1c.

Why insulin resistance drives PCOS

Hyperinsulinemia stimulates theca cells in the ovary to increase androgen production while simultaneously suppressing hepatic SHBG synthesis, thereby increasing free androgens (Escobar-Morreale, 2018).
Gut dysbiosis and endotoxemia (LPS exposure) promote low-grade inflammation and worsen insulin signaling, propagating ovarian dysfunction (Zhang et al., 2019).

Atypical PCOS phenotypes I see

Lean, athletic women with:
- Severe dysmenorrhea or irregular cycles
- Elevated LH: FSH
- High free T with normal total T
- High DHEA-S
- Minimal or no hirsutism/acne

This pattern demands a gut–metabolic workup even when body composition appears healthy. I frequently include stool microbiome testing when symptoms suggest dysbiosis.

Evidence-Based Treatment Algorithms for PCOS

My approach integrates metabolic therapy, targeted pharmacology, nutrition, and neuromusculoskeletal care.

Normalize insulin signaling

Metformin: Start low (e.g., 500 mg nightly) and titrate slowly to 1,500–2,000+ mg/day as tolerated to reduce hepatic gluconeogenesis and improve insulin sensitivity. GI side effects often attenuate with gradual titration and extended-release forms (Rena et al., 2017).
GLP-1 receptor agonists (e.g., semaglutide, exenatide): Improve glucose-dependent insulin secretion, delay gastric emptying, reduce appetite, and facilitate weight loss; randomized trials show improved metabolic and reproductive outcomes in PCOS (Kahal et al., 2021; Elkind-Hirsch et al., 2008).
Mechanistic payoff: Lower insulin raises SHBG and reduces androgenic “noise,” restoring ovulatory signaling.

Manage androgenic symptoms while root-cause care takes hold

Spironolactone: An aldosterone antagonist with androgen receptor–blocking activity; effective for hirsutism, acne. Typical doses 50–100 mg/day; allow 6–12 months for maximal effect (Brown et al., 2009).
Combined oral contraceptives (COCs) with antiandrogenic progestins (e.g., drospirenone-containing formulations) can raise SHBG and reduce free T; useful for cycle control and symptom relief when pregnancy is not desired (Teede et al., 2018).
Caution: Symptom control does not correct the insulin–ovary axis; keep metabolic therapy central.

Nutrition, gut health, and inflammation

Anti-inflammatory, Mediterranean-style diet with adequate protein, fiber, and omega-3 fatty acids improves insulin sensitivity and reduces ovarian androgen production (Barrea et al., 2019).
Intermittent fasting (time-restricted eating) may improve insulin sensitivity and weight in appropriately selected patients; ensure adequate caloric intake and avoid in those with disordered eating tendencies (Patterson & Sears, 2017).
Microbiome support: Address dysbiosis, SIBO, and intestinal permeability where indicated; diet, prebiotic fiber, and evidence-based probiotics can improve metabolic parameters.

Movement and integrative chiropractic

Consistent resistance training and aerobic exercise improve GLUT4 translocation, mitochondrial function, and insulin sensitivity. In my clinic, we pair individualized spinal and joint care with corrective exercise to reduce pain-related movement avoidance and enhance adherence.
Autonomic balance matters: Many PCOS patients show sympathetic dominance; hands-on care and breathing-based neuromuscular retraining can reduce allostatic load and support ovulatory recovery.

Fertility trajectory

Expect cycles and ovulation to normalize over months to years as insulin sensitivity improves. I have seen patients regain regular ovulation and conceive after systematic, sustained metabolic and gut care—even in those previously considered “lean and healthy.”

Clinical pearls and cautions

Start androgen therapy cautiously in PCOS or insulin-resistant women with low SHBG. Given the higher free fraction, standard doses can overshoot, increasing the risk of side effects. Start low and titrate slowly if testosterone therapy is clinically indicated for other reasons.
Obtain LH and androgen panels in premenopausal patients with menstrual complaints or infertility—even if phenotype is nonclassic.
Consider GI testing (e.g., stool analysis) when symptoms or history suggest dysbiosis, IBS, or food-triggered inflammation.

SHBG: What to Avoid and What to Embrace

Common misconception

“Lower SHBG to increase free T.” This treats the lab number, not the disease process.

What to avoid

Strategies that raise insulin (e.g., high refined carbohydrate load) just to lower SHBG.
Unnecessary suppression of SHBG may worsen cardiometabolic risk.

What to embrace

Improve insulin sensitivity through nutrition, exercise, sleep optimization, stress modulation, and gut care.
Use medications like metformin and GLP-1 receptor agonists to shift the metabolic field when lifestyle alone is insufficient.

In my practice, when we prioritize insulin sensitivity and inflammation control, SHBG trends upward into healthier ranges, free testosterone normalizes relative to total testosterone, and symptoms improve without chasing lab artifacts.

PSA, Percent Free PSA, and Prostate MRI: Smarter Men’s Health

PSA screening has evolved. A single total PSA value is an imperfect signal. Two tools improve decision-making:

Percent free PSA (%fPSA): The fraction of PSA not bound to serum proteins. Lower %fPSA indicates a higher likelihood of malignancy at a given total PSA.
PSA velocity: The year-over-year change in PSA. Faster rises suggest higher risk.

How I interpret PSA in practice

If total PSA is elevated (e.g., >4.0 ng/mL), I obtain percent free PSA. General rules supported by meta-analyses:
- %fPSA <10% = higher probability of prostate cancer
- %fPSA 10–20% = intermediate zone; consider prostatitis treatment if symptomatic and retest in ~3 months
- %fPSA >20% = lower probability; continue surveillance
Consider PSA velocity: An increase >0.35–2.0 ng/mL/year—context-dependent—merits further evaluation even if the absolute PSA is “within range” (Vickers et al., 2011).
Many benign factors elevate total PSA—intercourse, cycling, digital stimulation, BPH, prostatitis—but they do not significantly affect %fPSA, which is why I lean on percent free PSA for triage.

Imaging that changes outcomes

If risk remains concerning (low %fPSA, rapid velocity, suspicious DRE, or persistent PSA elevation), I order a 3 Tesla multiparametric prostate MRI (mpMRI). This modality improves lesion detection and helps target biopsies, reducing unnecessary procedures (Ahmed et al., 2017).
Most patients prefer an MRI over immediate biopsy, and mpMRI adds diagnostic clarity, including detection of chronic or acute prostatitis—a common cause of PSA bumps that I diagnose frequently.

Practical pearls

Finasteride lowers total PSA by roughly ~50% but does not meaningfully change %fPSA—interpretation should be adjusted accordingly.
Counsel patients to avoid prostate stimulation (e.g., ejaculation, vigorous cycling) for 48–72 hours before PSA sampling to reduce noise in total PSA.
If PSA and %fPSA suggest low risk, recheck in 3 months rather than rushing to biopsy.

Testosterone therapy timing

When PSA and urologic evaluation are reassuring, testosterone therapy can proceed with routine monitoring. I coordinate closely with urology, recognizing that practice styles vary.

DHEA Physiology, Brain Receptors, and When to Treat

Dehydroepiandrosterone (DHEA) and its sulfated form, DHEA-S, are produced primarily by the adrenal cortex and function as both endocrine prohormones and neurosteroids, with receptors and actions in the brain. Levels peak in the 20s and decline steadily with age. In both sexes, suboptimal DHEA can present as low vitality, depressed mood, impaired stress tolerance, and reduced sexual function—even when testosterone looks “good.”

Why DHEA matters

Neurosteroid action: DHEA modulates GABAergic and glutamatergic tone, supporting mood, cognition, and arousal (Maninger et al., 2009).
Peripheral conversion: DHEA can be converted to androgens and estrogens via tissue-specific enzymes; in women, a portion is converted to DHT in peripheral tissues, contributing to libido and sexual response.
Immunometabolic effects: DHEA has anti-inflammatory properties and may influence endothelial function and bone metabolism.

Clinical patterns I see

Women with adequate total and free testosterone who remain symptomatic for low libido or anorgasmia sometimes have low DHEA-S in the double digits. Carefully titrated DHEA supplementation often improves sexual function and overall well-being.
In men and women with persistent fatigue and low mood despite thyroid/hormone optimization, DHEA can be the missing link.

Dosing logic

I typically optimize thyroid and sex hormones first; DHEA often rises when metabolic stress decreases.
If DHEA-S remains suboptimal:
- Women: 5–10 mg/day compounded DHEA; reassess at ~6 weeks
- Men: 20 mg/day compounded DHEA; reassess at ~6 weeks
- Over-the-counter options vary in potency; when used, I start around 25 mg/day with close follow-up.
Monitor for androgenic side effects, especially in PCOS (who often already have high DHEA-S); avoid in hyperandrogenic phenotypes.

Evidence notes

Studies link low DHEA-S to reduced well-being, depression, and sexual dysfunction, with improvements seen in targeted supplementation cohorts (Arlt et al., 1999; Wierman et al., 2014). Age-associated decline is robust and correlates with multiple health outcomes.

Why Integrative Chiropractic Care Belongs in Endocrine-Metabolic Programs

The neuromusculoskeletal system interfaces with the endocrine and immune systems through shared inflammatory and autonomic pathways. Here is how integrative chiropractic care fits, based on observations from my clinic and the scientific literature:

Mechanistic bridges

Inflammation: Chronic pain amplifies IL-6 and TNF-α signaling, worsening insulin resistance. By reducing nociceptive drive and improving joint mechanics, manual therapies can lower inflammatory load and facilitate activity.
Autonomic balance: Spinal and rib mechanics influence sympathetic/parasympathetic tone. Improved thoracic mobility and diaphragmatic function promote vagal activity, which supports glycemic control and gut motility—both key to the gut–ovary axis.
Movement competency: Targeted strength and mobility programs enhance GLUT4 activity in skeletal muscle, thereby improving insulin sensitivity and supporting healthy SHBG levels.

In practice at Chiromed

We build individualized plans that synchronize:
- Spinal and extremity joint care to enable pain-free training
- Progressive resistance training emphasizing posterior chain and hip mechanics
- Aerobic conditioning at sustainable intensities
- Breathing retraining and sleep hygiene to normalize cortisol rhythms
This approach improves adherence to metabolic prescriptions, enabling the nutrition and pharmacology to “land” in real life.

Search-optimized section title Practical Protocols and Case-Style Reasoning

Putting it all together, here is how I apply the logic in daily care.

When SHBG is low, and symptoms suggest androgen deficiency

Evaluate metabolic health: fasting insulin, lipids, liver enzymes, hs-CRP, A1c.
Address insulin resistance first-line with nutrition, exercise, sleep, and stress management; consider metformin and/or GLP-1 RAs.
If symptoms persist, carefully optimize testosterone with awareness that low SHBG increases free fraction—start low, titrate to symptom relief and physiologic targets.

When PCOS is likely, but the phenotype is atypical

Order LH, FSH, total and free T, SHBG, DHEA-S, fasting insulin/glucose, and consider stool testing.
Begin metabolic therapy plus symptom-directed therapy (spironolactone or COCs if appropriate and pregnancy not desired).
Integrate resistance training and chiropractic-guided movement plans to accelerate insulin sensitivity and ovulatory recovery.

When initiating or adjusting DHEA

Confirm suboptimal DHEA-S and symptom alignment (low mood, libido, vitality).
Start low, reassess in 6–8 weeks, and monitor for androgenic side effects.
Avoid in hyperandrogenic PCOS unless clearly indicated and monitored.

When PSA is elevated or changing fast

Obtain percent free PSA and calculate velocity.
If %fPSA <10% or velocity is concerning, proceed to 3T mpMRI; if prostatitis is suspected, treat and retest.
Collaborate with urology based on mpMRI and clinical findings; delay testosterone changes until evaluation clarifies risk.

Why We Use Each Technique: The Physiology Behind the Protocols

Metformin: Reduces hepatic gluconeogenesis and improves peripheral insulin sensitivity via AMPK activation; lowers insulin, allowing SHBG to normalize and free T to calm down.
GLP-1 receptor agonists: Enhance glucose-dependent insulin secretion, reduce appetite, and reduce systemic inflammation; improved ovulatory function reported in PCOS.
Spironolactone: Direct androgen receptor blockade plus inhibition of 5α-reductase at higher doses; symptom relief while metabolic causes are corrected.
DHEA: Restores neurosteroid tone and supports sexual function with selective peripheral conversion; used when clinically and biochemically indicated.
Integrative chiropractic and movement: Improves neuromechanics and reduces pain, enabling training volume and intensity that improve insulin sensitivity; enhances autonomic balance affecting gut and endocrine axes.

Final Takeaways for Patients and Providers

Think metabolically first: Low SHBG is often a metabolic distress signal, not a target to suppress.
PCOS can be lean and subtle: Free T, LH: FSH, and DHEA-S mapping, plus gut assessment, can catch atypical cases.
Combine symptom control and root-cause therapy: Use spironolactone or COCs for hirsutism/acne while you restore insulin sensitivity and gut health.
Use smarter PSA strategies: Percent free PSA and PSA velocity reduce unnecessary biopsies and guide timely imaging with 3T mpMRI.
Integrate care: When manual therapy, structured exercise, and metabolic medicine are aligned, recovery timelines shorten and outcomes improve.

References

Ahmed, H. U., El-Shater Bosaily, A., Brown, L. C., Gabe, R., Kaplan, R., Parmar, M. K., … Emberton, M. (2017). Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. The Lancet, 389(10071), 815–822.

Arlt, W., Callies, F., van Vlijmen, J. C. M., Koehler, I., Reincke, M., Bidlingmaier, M., … Allolio, B. (1999). Dehydroepiandrosterone replacement in women with adrenal insufficiency. New England Journal of Medicine, 341(14), 1013–1020.

Barrea, L., Marzullo, P., Muscogiuri, G., Di Somma, C., De Alteriis, G., Colao, A., & Savastano, S. (2019). Nutritional aspects of PCOS: an update. Advances in Nutrition, 10(2), 270–292.

Brown, J., Farquhar, C., Lee, O., Toomath, R., & Jepson, R. (2009). Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne. Cochrane Database of Systematic Reviews, (2), CD000194.

Ding, E. L., Song, Y., Manson, J. E., Hunter, D. J., Lee, C.-C., Rifai, N., … Liu, S. (2009). Sex hormone–binding globulin and risk of type 2 diabetes in women and men. JAMA, 301(17), 1777–1786.

Elkind-Hirsch, K., Marrioneaux, O., Bhushan, M., Vernor, D., & Bhushan, R. (2008). Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in obese polycystic ovary syndrome. Journal of Clinical Endocrinology & Metabolism, 93(7), 2670–2678.

Escobar-Morreale, H. F. (2018). Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Human Reproduction Update, 24(6), 671–698.

Kahal, H., Aburima, A., Ungvari, T., Rigby, A. S., Coady, A. M., Vince, R. V., & Kilpatrick, E. S. (2021). The effect of GLP-1 receptor agonists on cardiovascular risk factors in women with PCOS. Endocrine, 71, 199–206.

Maninger, N., Wolkowitz, O. M., Reus, V. I., Epel, E. S., & Mellon, S. H. (2009). Neurobiological and neuropsychiatric effects of DHEA and DHEA-S. Psychoneuroendocrinology, 34(3), 273–286.

Patterson, R. E., & Sears, D. D. (2017). Metabolic effects of intermittent fasting. Annual Review of Nutrition, 37, 371–393.

Rena, G., Hardie, D. G., & Pearson, E. R. (2017). The mechanisms of action of metformin. Nature Reviews Molecular Cell Biology, 19(1), 31–44.

Selva, D. M., Hogeveen, K. N., Innis, S. M., & Hammond, G. L. (2007). Monosaccharide-induced lipogenesis regulates the human hepatic sex hormone–binding globulin gene. Journal of Clinical Investigation, 117(12), 3979–3987.

Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., … International PCOS Network. (2018). Recommendations from the international evidence-based guideline for the assessment and management of PCOS. Human Reproduction, 33(9), 1602–1618.

Vickers, A. J., Savage, C., O’Brien, M. F., Lilja, H. (2011). Systematic review of pretreatment prostate-specific antigen velocity and doubling time as predictors for prostate cancer. Journal of Clinical Oncology, 29(33), 447–453.

April 17, 2026

Failure to Yield Left-Turn Accidents: Injury Recovery

A ChiroMed Guide to T-Bone Crashes, Injury Recovery, and Restoring Mobility

A “Failure to Yield Left Turn” accident happens when a driver turns left across active traffic before the road is truly clear. In many of these crashes, the turning vehicle ends up partially blocking the lane, and the front of the oncoming vehicle strikes the side of the turning vehicle. That is why this crash is often called a “T-bone” or side-impact collision. Under Texas law, a driver turning left must yield the right of way to oncoming traffic that is already in the intersection or close enough to be an immediate hazard. (Texas Legislature, 2025; Daniel Stark, 2026).

For ChiroMed patients, this matters because side-impact crashes often create more than one injury at the same time. The force can twist the neck, compress the shoulder, jar the lower back, and strain the soft tissues on one side of the body. ChiroMed describes its model as a multidisciplinary, patient-centered approach led by Dr. Alex Jimenez, a dual-licensed chiropractor and advanced practice nurse practitioner, offering services including chiropractic care, rehabilitation, acupuncture, nutrition, and treatment for whiplash and severe auto accident injuries. (ChiroMed, 2026).

What This Crash Is Really Called

The best way to understand this crash is to separate the legal problem from the physical impact.

Failure to Yield Right of Way: This is a legal violation when a left-turning driver enters the path of oncoming traffic.
T-bone collision: This describes the shape of a crash in which one vehicle strikes the side of another.
Side-impact collision: another common term for the same type of hit.
“Sticking out” accident: This is an informal description people use when the turning car is left protruding into an active lane.
Improper median or lane positioning: In some cases, the driver also misuses the median opening or fails to line up correctly before finishing the turn. Texas DPS materials include “improper lane or location – median” as a recognized offense-code description. (Texas DPS, 2009; TopDog Law, 2025; DCM&D Law, 2026).

So, in simple terms, the crash is usually a T-bone collision caused by failing to yield when making a left turn. If the vehicle is hanging out in the crossover or median break, poor positioning may also be part of the story. That technical detail can matter when police, insurers, and injury providers are trying to understand exactly how the crash happened. (Texas DPS, 2009; Texas Legislature, 2025).

Why Failure to Yield Left Turns Are So Dangerous

Left turns are risky because the driver has to judge speed, distance, timing, and space all at once. A small mistake can put the car directly in front of fast-moving traffic. Daniel Stark explains that unprotected left turns are especially dangerous because drivers may misjudge the speed of oncoming traffic, creep too far forward, or become impatient and try to beat traffic. Other legal summaries of T-bone crashes say the same pattern is common when a driver turns left without waiting for a safe gap. (Daniel Stark, 2026; DCM&D Law, 2026).

Common causes include:

poor judgment of distance or speed
rushing through a gap that is too small
creeping too far into the lane
poor visibility
distraction
trying to clear the median opening too quickly
assuming the oncoming driver will slow down or stop (Daniel Stark, 2026; TopDog Law, 2025).

Who Is Usually at Fault

In most of these crashes, the left-turning driver is usually at fault because that driver had the duty to wait until the way was clear. Texas Transportation Code Section 545.152 places that duty directly on the left-turning driver. Legal explainers on left-turn and T-bone crashes also consistently say that a driver who turns into oncoming traffic is usually responsible for the collision. (Texas Legislature, 2025; TopDog Law, 2025; DCM&D Law, 2026).

However, “usually” does not mean “always.” A fault can become shared if the oncoming driver was speeding, distracted, impaired, or ran a red light. That is why investigators often review witness statements, traffic signals, vehicle damage, and final vehicle positions before reaching a full conclusion. (TopDog Law, 2025; Uptown Injury, 2025).

Common Injury Patterns in a T-Bone Crash

Side-impact crashes can be serious because there is less space between the occupant and the point of impact. NCBI’s StatPearls notes that frontal and near-side collisions commonly create head, neck, chest, and abdominal injuries. Research on side collisions also shows that injury risk is often higher than in frontal crashes because there is less vehicle structure to absorb the impact on the struck side. (Toney-Butler & Varacallo, 2023; Frampton et al., 1998).

After a failure-to-yield left-turn crash, common injuries may include:

whiplash and neck strain
shoulder pain and reduced motion
rib and chest wall pain
low back pain
hip or pelvic pain
headaches
numbness or tingling
bruising and soft tissue injury
disc irritation or nerve-related symptoms
in more serious cases, abdominal injury, fracture, or concussion-related symptoms (Toney-Butler & Varacallo, 2023; Yadla et al., 2008).

Whiplash is one of the most common injuries after a crash because the head and neck are suddenly forced to move. The Mayo Clinic explains that whiplash often causes neck pain, stiffness, headaches, and limited range of motion. A broader review of whiplash-associated disorders also lists arm pain, paresthesias, headache, dizziness, and concentration problems among the common symptoms. (Mayo Clinic, 2024a; Yadla et al., 2008).

Why Some Symptoms Do Not Show Up Right Away

One of the biggest mistakes people make after a side-impact crash is assuming they are fine because pain has not started yet. ChiroMed’s own MVA education page notes that whiplash symptoms may not show immediately because adrenaline can mask pain at first, with discomfort sometimes appearing within 24 hours. Research on late whiplash patterns also reports that headache and neck pain can begin hours after impact rather than right away. (ChiroMed, 2026; Astrup et al., 2022).

That is why patients should pay attention to delayed signs such as:

neck stiffness
headaches
dizziness
shoulder tightness
low back pain
numbness or tingling
reduced range of motion
pain that worsens the next day or over the next week (ChiroMed, 2026; Mayo Clinic, 2024b).

How ChiroMed Approaches Recovery After a T-Bone Accident

ChiroMed presents auto-injury care as more than just basic symptom relief. Its materials describe a team-based model that combines chiropractic care with rehabilitation and broader clinical support. On the ChiroMed site, Dr. Alex Jimenez is described as a dual-licensed provider who leads a multidisciplinary team focused on holistic, patient-centered care for whiplash, neck and back pain, complex personal injuries, and severe auto accident rehabilitation. ChiroMed also explains that its nurse practitioners help bridge conventional and alternative medicine by working with chiropractors and other specialists to build comprehensive plans. (ChiroMed, 2026a; ChiroMed, 2026b).

For a patient hurt in a failure-to-yield left-turn crash, an integrative plan may include:

chiropractic adjustments or mobilization to improve joint movement
soft tissue work or massage to calm muscle tension
rehabilitation exercises to rebuild strength and coordination
posture and movement retraining
imaging or deeper clinical evaluation when symptoms suggest a more complex injury
supportive therapies such as acupuncture, depending on the case (ChiroMed, 2026a; ChiroMed, 2026c).

ChiroMed’s MVA page states that chiropractic care after collisions can help reduce joint inflammation, improve mobility, and support long-term recovery through spinal adjustments, soft-tissue therapies, rehabilitation exercises, and individualized care plans. Its broader injury-recovery content also highlights detailed documentation and integrated treatment when legal and insurance issues are part of the case. (ChiroMed, 2026c; ChiroMed, 2026d).

Why Physical Rehabilitation Matters

Good recovery after a T-bone crash is not just about getting the pain to calm down. It is also about restoring motion, stability, endurance, and safe daily function. Mayo Clinic says active physical therapy programs can reduce pain and disability in whiplash cases, and those programs often include range-of-motion work, cervical strengthening, coordination training, and functional exercises. Mayo also notes that simple movement exercises can help patients return to normal activities. (Mayo Clinic, 2022; Mayo Clinic, 2024b).

That rehab focus fits with ChiroMed’s site style and services. The clinic emphasizes rehabilitation as part of its integrated care model, which is important for patients who need more than a quick adjustment. A person recovering from a side-impact crash may need a staged plan that starts with pain control, then moves into mobility work, then into strengthening and functional recovery. (ChiroMed, 2026a; ChiroMed, 2026c).

Dr. Alex Jimenez’s Dual-Scope Perspective

One of the strongest site-specific angles for ChiroMed is Dr. Alex Jimenez’s dual-scope background. ChiroMed describes him as both a chiropractic doctor and an advanced practice nurse practitioner, and its injury pages present the combined skill set as useful for evaluating complicated motor vehicle cases. ChiroMed also highlights medical precision, chiropractic expertise, and documentation support in injury-related care. (ChiroMed, 2026a; ChiroMed, 2026e).

For patients injured in a failure-to-yield left-turn crash, that dual perspective can be valuable because side-impact collisions may involve more than one body system at once. A patient may have neck strain, nerve symptoms, shoulder dysfunction, low back pain, and soft-tissue injury, all from the same event. A combined medical and chiropractic perspective can help link crash mechanics to the patient’s symptoms and recovery needs. (Toney-Butler & Varacallo, 2023; ChiroMed, 2026e).

The Bottom Line

A “Failure to Yield Left Turn” crash is usually both a legal and physical event. Legally, it is most often a failure-to-yield problem on the part of the turning driver. Physically, it is often a T-bone or side-impact collision that can create neck, back, shoulder, rib, pelvic, and nerve-related injuries. Because symptoms can be delayed and injury patterns can be complex, patients often benefit from a thorough, integrative recovery plan. For a ChiroMed audience, that means looking beyond short-term pain and focusing on accurate diagnosis, whole-body treatment, rehabilitation, and long-term return to function. (Texas Legislature, 2025; Mayo Clinic, 2024b; ChiroMed, 2026a).

References

Astrup, J., Rosenbaum, S., & Feldt-Rasmussen, U. (2022). The Whiplash Disease Reconsidered. Frontiers in Neurology.
ChiroMed. (2026a). ChiroMed – Integrated Medicine Holistic Healthcare in El Paso, TX.
ChiroMed. (2026b). About Us.
ChiroMed. (2026c). Chiropractic Treatment for Optimal Health After An MVA.
ChiroMed. (2026d). From Injury to Compensation: How Chiropractors and Nurse Practitioners Support Personal Injury Recovery After Car Accidents.
ChiroMed. (2026e). Gastrointestinal Impact After Motor Vehicle Accidents: Treatment Through Integrative Medicine.
Daniel Stark. (2026). Why Left Turns Are So Dangerous.
DCM&D Law. (2026). Who Is at Fault in a T-Bone Car Accident?.
Mayo Clinic. (2024a). Whiplash – Symptoms and causes.
Mayo Clinic. (2024b). Whiplash – Diagnosis and treatment.
Mayo Clinic. (2022). Update on medical management of whiplash-associated disorders.
Texas Department of Public Safety. (2009). Driver License / Identification Card Inquiries.
Texas Legislature. (2025). Transportation Code Chapter 545, Section 545.152.
Toney-Butler, T. J., & Varacallo, M. (2023). Motor Vehicle Collisions. StatPearls.
TopDog Law. (2025). Who Is at Fault for a T-Bone Accident?.
Uptown Injury. (2025). Who Is Liable in a T-Bone Car Accident?.
Yadla, S., Ratliff, J. K., & Harrop, J. S. (2008). Whiplash: Diagnosis, treatment, and associated injuries. Current Reviews in Musculoskeletal Medicine.

Year: 2026

BHRT: What to Expect With Hormones & Pellet Therapy

Abstract

Revolutionizing the Patient Experience: A Streamlined Clinical Workflow

The Critical Role of Informed Consent and Patient Education

Case Study 1: Decoding Menopausal Symptoms in a 59-Year-Old Female

Comprehensive Lab Analysis: Uncovering the Root Causes

The Treatment Plan: BHRT and Integrative Chiropractic Care

Assessing Hormone Therapy- Video

Case Study 2: Addressing Andropause in a Male Patient

Interpreting the Male Lab Panel

The Comprehensive Treatment Protocol for Andropause

The Art and Science of Pellet Insertion Technique

Follow-Up and Long-Term Management: The Art of Titration

References

Evidence-Based Integrative Hormone Care

Endometrial Health, Thrombosis Safety, Pain, Hair, and Patient-Centered Systems

Abstract

Introduction: My Integrative Approach to Complex Care

Core Patient-Centered Workflow: Systems that Prevent Dropout and Improve Safety

Integrative Chiropractic Care: The Physiologic Amplifier

Progesterone Physiology and Practical Use: Sleep, Mood, and Endometrial Stability

Endometrial Health: Thickness, Imaging, and Biopsy Decisions

Hormone Routes and Thrombosis Safety: What Leading Research Shows

Testosterone, Erythropoiesis, and Hematocrit: Mechanisms and Monitoring

Fertility and the Gonadal Axis: Counseling and Alternatives

Hair Physiology, DHT, and Shedding: Understanding the Transition

Acne, Aromatization, and Dose Smoothing

Hypertension and Beta Blockers: Modern First-Line Reasoning

Beyond hormones, careful pharmacology matters:

Micro-Interventions and Clinical Checklists: Making Care Stick

Putting It Together: A Patient Journey Example

Why Integrative Chiropractic Belongs in This Care

Key Takeaways You Can Use Today

References

Bioidentical Hormones Benefits Overview for Patient Wellness

Navigating Hormonal Health: An Integrative Approach to Wellness

Foundations of Bioidentical Hormone Replacement: Source and Application

Navigating the Transition from Birth Control to BHRT

The Risks of Prolonged Oral Contraceptive Use

The Transition Protocol

The Critical Role of Integrative Chiropractic Care

Addressing Specific Conditions: Anxiety, Migraines, and Sleep

Perimenopausal Anxiety and PMS

Menstrual Migraines

Sleep, Growth Hormone, and the Modern Epidemic

Advanced Topics and Clinical Pearls

Topical Estrogen on the Face

Testing and Monitoring

Interacting with Other Medical Professionals

References

Delayed Car Accident Symptoms: Hidden Injuries

Red Flags and How Integrative Chiropractic Care Can Help

Why do delayed symptoms happen after a crash

The most common hidden symptoms to watch for

Headaches that do not go away

Neck pain and stiffness

Back pain and limited mobility

Numbness, tingling, and pins and needles

Abdominal pain, swelling, or bruising

Emotional distress and mental fog

Red flags that need immediate medical care

How an integrative chiropractic clinic can help after a crash

A ChiroMed-style approach to delayed accident symptoms

Clinical observations from Dr. Alexander Jimenez, DC, APRN, FNP-BC

What to do in the days after a car accident

Smart next steps

Final thoughts

References

A Clinical Approach Overview on Bioidentical Hormones

Abstract

The Overlooked Symptoms of Hormone Insufficiency

The Clinical Journey: Screening, Labs, and Treatment Planning

Step 1: Patient Screening and Documentation

Step 2: Foundational Lab Work to Establish Your Hormonal Baseline

Step 3: The Consultation and Personalized Treatment Plan

Evaluating Hormone Replacement Therapy Options

Oral Medications

Transdermal Creams and Gels

Injections